hg_235328.1

Basic information about the TSS

---

TSS ID: hg_235328.1 Species: human Chr: chr14		Start: 74494371 End: 74494389 Strand: -
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: ENST00000556009.5 Distance: 195 GeneID: 10577 HGNC/MGI_ID: HGNC:14537 UniProt_ID: H0YIZ1

Gene_name: NPC intracellular cholesterol transporter 2 Gene_symbol: NPC2 Gene_synonyms: EDDM1 HE1 NP-C2 Gene_source: HGNC:14537

TATA-Box annotation

---

Distance to TSS:	43
Nearest PromoterID:	NM_001290130
Entrez ID:	55624
Nearest Unigene:	Hs.525134
Nearest Refseq:	NM_017739
Nearest Ensembl:	ENSG00000085998
Gene Name:	NPC intracellular cholesterol transporter 2
Gene Alias:	GNTI.2|GnT I.2|LGMD2O|LGMDR15|MEB|MGAT1.2|RP76|gnT-I.2
Gene Description:	protein O-linked mannose N-acetylglucosaminyltransferase 1 (beta 1,2-)
Gene Type:	protein-coding
CpG%:	0.015
GC%:	0.537313
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@NPC2 p2@NPC2 p3@NPC2 p4@NPC2 p5@NPC2
Sample		p1@NPC2	p2@NPC2	p3@NPC2	p4@NPC2	p5@NPC2
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	65.84	12.47	3.31	0.97	0.19
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	65.35	12.95	3.84	1.21	0.00
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	67.13	15.63	2.89	1.16	0.39
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	59.25	12.68	3.95	0.42	0.00
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	59.17	15.07	4.95	1.35	0.90
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	61.24	10.08	3.88	1.55	0.00
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	70.59	11.55	5.66	1.09	0.87
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	53.05	13.81	4.36	0.48	0.48
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	57.49	10.26	3.63	1.50	0.85
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	22.61	7.54	2.32	1.16	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	22.23	8.49	1.62	0.40	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	19.11	6.10	2.85	0.41	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	247.91	44.81	14.99	5.64	1.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	249.58	39.39	17.29	4.51	1.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	235.80	45.01	9.00	3.95	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	255.51	35.46	17.60	4.28	1.51
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	261.00	41.06	17.69	4.59	0.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	245.08	35.43	15.19	2.53	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	243.12	38.92	17.06	3.73	1.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	283.58	52.80	17.75	6.47	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	268.77	40.50	17.51	6.01	1.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	294.50	46.44	21.06	4.14	1.04
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	266.53	44.59	15.77	2.71	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	255.04	42.22	16.74	2.91	1.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	282.76	47.47	16.51	2.58	1.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	256.06	44.00	16.14	3.48	1.58
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	293.41	48.35	19.78	3.30	0.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	288.56	53.52	17.21	5.89	1.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	271.84	42.00	13.89	5.33	1.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	262.22	55.01	14.12	5.25	0.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	270.47	43.75	14.44	5.23	1.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	266.89	47.48	15.24	5.28	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	271.17	40.73	17.09	3.80	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	373.59	55.58	25.24	4.95	0.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	282.73	51.98	17.76	6.73	0.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	237.61	46.56	13.03	4.60	1.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	257.93	45.17	12.47	4.50	0.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	258.31	42.11	17.13	3.63	1.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	256.87	46.73	15.94	4.05	1.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	230.70	41.53	12.00	4.08	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	240.44	45.88	14.12	3.29	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	304.35	48.60	16.98	4.54	1.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	272.47	55.89	19.19	3.80	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	250.88	46.85	10.31	6.47	0.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	238.32	43.17	13.25	5.82	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	254.75	53.51	12.10	4.65	1.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	257.66	47.50	11.76	6.96	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	256.02	49.77	14.90	2.68	2.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	259.48	47.87	13.64	4.55	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	276.00	62.28	18.00	7.68	2.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	293.49	51.44	18.45	6.56	0.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	305.99	53.37	18.90	5.78	2.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	643.64	69.96	13.99	13.99	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	254.79	39.39	12.07	3.90	2.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	231.97	32.81	16.90	0.99	2.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	555.38	40.27	26.01	7.55	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	424.34	50.52	27.55	5.05	0.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	228.82	43.11	11.67	1.62	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	216.15	39.83	13.17	3.85	0.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	356.45	44.63	23.26	5.66	1.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	193.89	41.60	9.87	3.53	2.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	182.82	31.96	12.90	1.68	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	285.82	30.25	19.90	6.37	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	259.58	41.45	12.91	2.72	0.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	183.91	34.12	7.80	3.57	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	122.47	26.27	6.39	2.13	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	339.44	32.33	32.33	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	465.95	55.28	47.38	7.90	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	107.25	22.91	4.88	2.44	0.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	120.50	28.76	8.43	3.47	2.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	94.29	22.99	4.69	1.88	1.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	118.23	46.70	6.29	2.32	1.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	94.35	25.68	8.35	5.57	2.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	88.67	34.24	3.36	2.45	2.14
Adipocyte - breast, donor1	11376-118A8	200.04	50.37	27.40	3.48	2.22
Adipocyte - breast, donor2	11327-117E4	204.54	39.30	23.90	2.73	1.28
Adipocyte - omental, donor1	11473-119C6	175.70	55.34	24.17	7.76	2.80
Adipocyte - omental, donor2	11474-119C7	145.01	42.61	20.18	4.48	1.49
Adipocyte - omental, donor3	11475-119C8	199.95	58.28	15.41	6.36	3.35
Adipocyte - perirenal, donor1	11476-119C9	266.68	39.56	16.59	8.29	3.83
Adipocyte - subcutaneous, donor1	11259-116F8	138.54	30.79	17.59	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	141.81	45.16	13.55	2.26	1.81
Adipocyte - subcutaneous, donor3	11408-118E4	119.56	42.05	8.52	9.04	4.00
Adipocyte differentiation, day04, donor1	13019-139D4	234.10	68.45	21.32	5.48	2.74
Adipocyte differentiation, day04, donor2	13022-139D7	261.24	70.01	28.31	2.57	0.77
Adipocyte differentiation, day04, donor3	13025-139E1	298.57	73.32	30.94	5.02	2.51
Adipocyte differentiation, day04, donor4	13028-139E4	183.40	61.72	12.34	4.70	0.59
Adipocyte differentiation, day08, donor1	13020-139D5	176.95	49.23	16.41	3.78	0.80
Adipocyte differentiation, day08, donor2	13023-139D8	353.74	103.60	32.28	6.78	0.65
Adipocyte differentiation, day08, donor3	13026-139E2	276.19	56.52	25.06	7.46	2.13
Adipocyte differentiation, day08, donor4	13029-139E5	183.07	48.41	17.25	3.34	1.11
Adipocyte differentiation, day12, donor1	13021-139D6	304.43	49.08	39.09	5.41	1.66
Adipocyte differentiation, day12, donor2	13024-139D9	311.45	97.45	27.88	4.27	1.51
Adipocyte differentiation, day12, donor3	13027-139E3	204.86	56.29	27.82	2.62	1.96
Adipocyte differentiation, day12, donor4	13030-139E6	221.05	38.36	24.97	5.48	0.91
Alveolar Epithelial Cells, donor1	11510-119G7	126.19	26.52	12.60	2.65	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	86.06	10.04	5.38	2.15	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	124.59	26.36	19.17	1.20	1.20
Amniotic Epithelial Cells, donor1	11533-120A3	302.60	48.93	28.43	2.70	0.54
Amniotic Epithelial Cells, donor2	11613-122A2	317.96	90.37	30.12	1.67	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	257.01	51.98	29.17	2.88	0.21
Anulus Pulposus Cell, donor1	11248-116E6	131.59	42.91	11.67	7.21	0.80
Anulus Pulposus Cell, donor2	11463-119B5	116.09	30.12	6.61	6.61	1.47
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	124.90	32.35	10.78	3.15	1.35
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	95.95	27.35	10.85	3.91	1.74
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	89.89	8.56	10.70	6.42	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	123.75	40.06	11.96	3.59	1.20
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	115.08	27.82	12.65	2.53	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	91.09	25.08	9.24	1.98	0.66
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	104.94	32.49	9.42	2.92	2.27
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	93.69	26.70	11.17	2.43	0.97
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	105.12	26.13	11.28	2.97	1.19
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	98.30	25.99	8.66	3.01	1.13
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	91.43	29.75	8.71	5.08	1.45
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	86.51	20.06	8.78	3.76	1.25
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	95.22	28.99	8.73	2.80	0.82
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	83.25	23.20	8.19	2.73	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	87.31	24.88	8.29	2.26	1.21
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	111.44	27.33	7.50	5.89	1.07
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	88.99	26.07	9.26	2.46	1.13
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	88.20	21.92	11.23	2.41	0.80
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	106.32	26.34	5.85	5.85	2.93
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	94.54	26.37	8.96	2.32	1.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	74.44	18.01	10.81	1.20	2.40
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	92.04	21.24	14.16	3.54	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	90.57	23.16	7.03	1.72	1.20
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	104.87	16.78	16.78	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	105.34	39.80	6.80	3.40	1.46
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	113.46	29.60	11.00	4.93	1.14
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	105.39	18.17	6.06	3.63	1.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	114.01	27.93	9.69	3.99	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	89.14	25.65	8.12	2.78	1.71
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	86.20	23.49	7.48	2.58	1.29
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	86.33	23.93	12.67	3.75	1.41
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	89.07	25.72	7.40	2.57	1.61
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	102.02	24.97	7.85	2.85	2.14
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	76.63	25.74	11.11	2.34	0.58
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	87.31	26.49	8.13	4.82	1.81
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	110.48	15.44	11.88	4.75	1.19
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	105.78	29.50	8.14	3.05	3.56
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	103.15	24.20	8.91	3.57	0.76
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	78.15	22.87	6.99	3.81	3.18
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	104.86	27.19	9.49	3.88	1.29
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	85.31	27.52	12.49	3.18	1.27
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	83.80	20.59	11.89	2.90	1.45
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	70.86	22.67	4.72	1.89	2.83
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	89.51	24.92	11.70	2.71	1.53
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	62.54	23.16	13.90	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	82.39	29.58	14.79	2.11	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	90.27	28.09	8.79	2.36	1.07
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	101.08	21.66	9.02	3.01	1.20
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	93.31	29.89	9.48	3.64	2.19
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	99.54	26.21	10.80	3.68	0.46
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	76.51	15.30	12.75	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	107.79	32.54	10.42	2.03	1.02
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	92.90	24.15	8.46	4.34	2.27
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	89.35	27.23	5.81	3.98	2.45
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	107.07	31.55	7.17	6.21	1.91
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	87.14	24.39	6.87	3.33	0.89
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	91.55	18.31	7.63	3.05	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	95.82	21.60	7.20	3.88	3.88
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	79.17	18.80	7.68	2.65	1.59
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	81.05	26.17	3.63	5.09	0.36
Astrocyte - cerebellum, donor1	11500-119F6	173.05	45.69	13.51	4.42	1.72
Astrocyte - cerebellum, donor2	11580-120F5	140.01	37.48	13.35	6.68	1.54
Astrocyte - cerebellum, donor3	11661-122F5	84.74	25.59	3.78	2.52	2.73
Astrocyte - cerebral cortex, donor1	11235-116D2	124.79	41.48	7.67	8.37	3.14
Astrocyte - cerebral cortex, donor2	11316-117D2	80.40	26.21	7.12	2.59	1.94
Astrocyte - cerebral cortex, donor3	11392-118C6	119.03	39.83	7.91	4.77	2.09
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	36.58	30.05	1.15	3.10	0.57
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	30.32	22.30	0.88	2.76	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	29.13	23.67	0.57	1.93	0.11
Basophils, donor1	12241-129G9	300.76	76.37	16.48	7.06	1.05
Basophils, donor2	12242-129H1	226.22	49.07	18.40	8.30	0.72
Basophils, donor3	12243-129H2	293.26	85.99	17.05	6.76	0.88
Bronchial Epithelial Cell, donor1	11511-119G8	177.44	22.42	11.64	1.08	0.65
Bronchial Epithelial Cell, donor2	11591-120G7	89.61	7.77	5.03	1.37	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	459.11	50.21	43.04	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	128.04	13.18	15.06	1.88	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	134.96	16.22	14.14	2.08	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	87.28	12.21	8.52	1.61	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	250.12	32.57	18.53	1.44	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	56.47	17.11	1.85	2.68	0.10
Burkitt's lymphoma cell line:RAJI	10476-106I8	44.95	20.03	0.23	0.70	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	166.60	55.96	5.12	7.35	3.20
CD133+ stem cells - cord blood derived, pool1	12223-129E9	134.45	62.05	10.34	10.34	0.00
CD14+ Monocytes, donor1	11224-116B9	242.33	74.95	24.80	6.20	0.56
CD14+ Monocytes, donor2	11305-117B9	235.16	69.79	16.89	6.87	0.93
CD14+ Monocytes, donor3	11381-118B4	208.12	72.45	14.49	5.49	0.44
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	2077.54	594.39	209.74	29.72	5.94
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	1643.29	501.90	158.07	18.57	5.69
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	2050.03	508.56	197.24	26.63	4.27
CD14+ monocytes - mock treated, donor1	11863-125A9	501.87	132.12	47.27	9.25	1.59
CD14+ monocytes - mock treated, donor2	11873-125C1	415.80	91.43	41.64	7.54	0.60
CD14+ monocytes - mock treated, donor3	11883-125D2	522.59	121.76	36.96	8.77	1.90
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	447.12	110.65	47.21	10.04	0.84
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	351.91	72.59	36.71	6.90	0.55
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	513.96	99.17	35.70	7.69	0.99
CD14+ monocytes - treated with BCG, donor1	11860-125A6	399.63	114.94	28.78	10.18	1.37
CD14+ monocytes - treated with BCG, donor2	11870-125B7	434.79	102.73	30.80	8.19	1.60
CD14+ monocytes - treated with BCG, donor3	11880-125C8	755.61	154.95	58.11	10.88	1.52
CD14+ monocytes - treated with Candida, donor1	11868-125B5	427.05	78.90	27.39	7.96	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	397.61	62.84	25.35	4.22	0.53
CD14+ monocytes - treated with Candida, donor3	11888-125D7	549.13	89.86	21.08	6.66	1.11
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	450.71	118.26	41.35	6.10	1.34
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	401.69	91.79	34.52	5.39	0.60
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	734.32	145.11	62.25	5.62	1.46
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	472.21	102.50	39.58	7.32	0.69
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	369.84	68.77	24.88	5.88	0.45
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	406.35	85.98	28.81	4.80	0.44
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	480.42	125.89	36.58	8.88	2.15
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	557.75	125.44	48.50	10.47	1.57
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	652.27	138.87	59.34	10.10	1.68
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	414.08	94.79	30.13	7.35	1.47
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	303.65	50.37	14.09	3.17	0.70
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	401.87	86.87	31.59	3.07	1.75
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	394.96	107.41	27.03	9.76	2.09
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	397.69	101.47	29.73	6.32	1.12
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	738.04	160.15	65.10	12.93	1.94
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	383.69	86.40	27.85	7.37	0.82
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	304.35	53.55	22.95	4.17	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	546.81	98.36	42.22	4.41	0.70
CD14+CD16+ Monocytes, donor1	11789-124B7	821.94	192.68	40.11	14.82	2.18
CD14+CD16+ Monocytes, donor2	11801-124D1	931.60	214.59	41.12	16.40	3.93
CD14+CD16+ Monocytes, donor3	11912-125G4	1034.77	228.31	53.94	17.55	4.55
CD14+CD16- Monocytes, donor1	11788-124B6	523.38	169.11	21.65	13.24	1.56
CD14+CD16- Monocytes, donor2	11799-124C8	483.76	158.05	20.26	8.56	1.57
CD14+CD16- Monocytes, donor3	11910-125G2	379.72	131.33	23.19	9.81	0.89
CD14-CD16+ Monocytes, donor1	11790-124B8	1192.43	216.90	48.48	27.56	5.87
CD14-CD16+ Monocytes, donor2	11800-124C9	777.92	152.60	30.52	15.15	2.42
CD14-CD16+ Monocytes, donor3	11911-125G3	806.18	168.02	35.58	15.79	2.95
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	142.26	77.23	2.03	8.13	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	171.53	50.85	1.36	7.46	2.03
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	186.41	59.03	2.07	9.32	2.07
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	203.62	67.70	11.19	6.40	0.53
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	204.78	58.43	2.14	8.58	1.07
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	162.15	53.35	1.40	9.83	1.40
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	170.99	61.18	1.57	12.55	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	181.92	61.96	1.32	13.18	0.00
CD19+ B Cells, donor1	11544-120B5	73.97	31.23	4.11	3.29	0.00
CD19+ B Cells, donor2	11624-122B4	101.56	28.29	3.63	4.35	0.00
CD19+ B Cells, donor3	11705-123B4	79.26	31.80	3.53	5.55	0.50
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	67.48	31.52	5.25	4.44	1.62
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	56.73	30.76	5.19	1.20	0.40
CD34+ Progenitors, donor1	11545-120B6	125.51	45.18	5.02	7.03	0.00
CD34+ Progenitors, donor2	11625-122B5	124.72	29.78	11.80	5.06	2.81
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	125.50	58.62	3.38	4.51	0.75
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	151.98	57.50	4.51	6.76	0.45
CD4+ T Cells, donor1	11225-116C1	41.06	13.21	1.79	1.79	0.36
CD4+ T Cells, donor2	11306-117C1	56.34	16.53	0.61	4.90	0.61
CD4+ T Cells, donor3	11382-118B5	42.09	17.08	1.83	2.13	0.30
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	90.86	51.56	1.79	4.59	0.51
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	74.79	43.57	1.35	4.04	0.67
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	64.97	41.39	0.57	4.31	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	87.23	24.65	3.79	5.22	0.47
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	124.31	39.33	3.51	9.13	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	82.41	29.67	0.00	0.00	3.30
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	44.08	25.58	1.01	3.47	0.14
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	87.95	49.48	1.69	4.58	0.51
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	68.51	47.39	1.13	3.22	0.64
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	52.45	26.45	0.45	0.90	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	57.30	24.81	1.75	2.10	0.70
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	36.52	21.12	0.44	1.76	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	43.85	28.25	0.42	2.11	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	39.68	20.78	1.04	1.45	0.62
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	38.76	18.38	0.00	1.67	0.67
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	63.36	21.75	1.36	2.99	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	82.00	25.73	3.22	3.22	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	41.24	25.11	0.00	1.79	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	61.75	24.48	2.04	2.60	0.19
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	40.94	22.96	0.43	1.95	1.08
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	42.45	26.90	1.47	2.31	0.42
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	54.10	24.77	0.51	2.53	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	60.66	24.70	1.30	2.17	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	36.61	15.69	0.44	2.61	0.44
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	92.05	36.62	0.99	6.93	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	70.16	27.70	1.85	5.54	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	85.15	44.67	1.40	9.77	1.40
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	133.48	32.68	3.60	6.65	1.38
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	103.06	36.07	2.45	6.13	1.23
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	93.94	38.50	1.54	6.16	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	98.48	31.87	3.58	5.73	0.72
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	85.87	29.08	0.00	8.31	1.38
CD8+ T Cells, donor1	11226-116C2	33.07	12.44	1.64	1.96	0.00
CD8+ T Cells, donor2	11307-117C2	31.54	15.02	2.63	1.88	0.38
CD8+ T Cells, donor3	11383-118B6	29.04	11.61	1.51	3.79	0.00
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	19.04	16.06	0.46	0.69	0.23
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	19.41	16.06	1.44	1.68	0.24
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	18.88	13.41	1.09	1.37	0.27
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	26.72	19.51	2.40	1.80	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	19.92	12.72	0.96	0.96	0.96
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	20.92	14.10	1.82	1.82	0.23
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	19.34	9.13	1.30	0.65	0.22
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	18.16	7.90	1.58	1.58	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	16.42	12.43	0.94	0.47	0.47
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	17.51	11.17	2.11	0.30	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	16.85	12.78	1.16	0.87	0.29
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	11.19	12.79	0.80	1.87	0.27
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	16.63	9.63	0.44	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	23.68	10.02	1.37	0.91	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	20.14	8.20	2.98	0.75	0.75
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	27.01	17.29	1.80	1.44	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	22.44	16.98	0.29	1.15	0.29
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	15.79	14.38	2.59	1.41	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	12.04	13.31	1.58	0.63	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	13.23	9.84	1.54	1.23	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	15.71	11.86	0.96	0.96	0.32
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	11.47	8.41	0.00	0.38	0.76
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	11.82	8.67	0.79	0.79	0.39
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	16.64	6.81	0.00	0.00	0.76
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	25.69	17.67	6.42	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	24.48	14.69	2.80	0.70	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	15.03	15.03	1.00	1.00	2.00
Cardiac Myocyte, donor1	11525-119I4	246.74	80.42	69.45	5.48	0.00
Cardiac Myocyte, donor2	11605-120I3	276.69	46.94	38.54	1.48	0.49
Cardiac Myocyte, donor3	11686-122I3	290.65	30.10	17.05	2.84	0.74
Chondrocyte - de diff, donor1	11261-116G1	58.59	15.25	3.12	1.04	1.04
Chondrocyte - de diff, donor2	11338-117F6	68.59	14.93	3.20	1.07	1.78
Chondrocyte - de diff, donor3	11410-118E6	92.39	22.76	9.10	2.73	1.37
Chondrocyte - re diff, donor2	11339-117F7	324.08	103.85	49.24	8.06	2.69
Chondrocyte - re diff, donor3	11411-118E7	189.67	46.51	10.51	6.07	3.64
Ciliary Epithelial Cells, donor1	11242-116D9	328.67	69.31	40.74	6.89	2.30
Ciliary Epithelial Cells, donor2	11323-117D9	301.62	58.57	46.81	5.13	1.07
Ciliary Epithelial Cells, donor3	11399-118D4	360.27	63.10	51.68	5.84	0.44
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	164.42	58.05	18.71	5.32	2.66
Corneal Epithelial Cells, donor1	11526-119I5	146.45	23.71	13.17	0.88	0.66
Corneal Epithelial Cells, donor2	11606-120I4	143.34	11.38	6.83	1.14	0.00
Corneal Epithelial Cells, donor3	11687-122I4	146.22	18.66	12.53	1.79	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	488.35	166.58	48.04	5.12	0.66
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	539.35	187.35	52.67	8.52	1.26
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	603.87	148.38	44.86	13.80	3.45
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	426.67	139.31	45.14	5.94	0.76
Dendritic Cells - plasmacytoid, donor1	11228-116C4	1274.66	180.05	119.23	16.40	5.12
Dendritic Cells - plasmacytoid, donor2	11309-117C4	1559.05	262.45	143.63	25.46	5.22
Dendritic Cells - plasmacytoid, donor3	11385-118B8	1896.10	199.87	136.47	24.20	3.87
Endothelial Cells - Aortic, donor0	11207-116A1	81.72	18.68	10.01	3.17	0.83
Endothelial Cells - Aortic, donor1	11263-116G3	96.82	25.23	5.87	1.76	2.35
Endothelial Cells - Aortic, donor2	11340-117F8	98.98	20.93	10.18	1.41	1.13
Endothelial Cells - Aortic, donor3	11412-118E8	124.25	24.38	14.55	2.75	0.79
Endothelial Cells - Artery, donor1	11264-116G4	174.82	34.61	20.07	4.36	1.45
Endothelial Cells - Artery, donor2	11341-117F9	84.70	16.94	13.18	2.12	0.24
Endothelial Cells - Artery, donor3	11413-118E9	92.91	23.67	13.50	2.98	0.53
Endothelial Cells - Lymphatic, donor1	11236-116D3	469.90	68.27	60.73	5.76	1.99
Endothelial Cells - Lymphatic, donor2	11317-117D3	434.49	81.24	74.85	6.39	0.91
Endothelial Cells - Lymphatic, donor3	11393-118C7	253.43	52.15	29.32	3.95	1.41
Endothelial Cells - Microvascular, donor1	11265-116G5	110.53	29.12	12.18	3.57	1.19
Endothelial Cells - Microvascular, donor2	11342-117G1	55.71	14.58	6.25	1.56	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	107.90	30.20	10.07	2.69	0.28
Endothelial Cells - Thoracic, donor1	11266-116G6	97.23	21.61	11.20	3.60	2.40
Endothelial Cells - Thoracic, donor2	11343-117G2	99.06	34.07	8.39	3.14	1.05
Endothelial Cells - Umbilical vein, donor1	11243-116E1	206.62	47.96	27.09	4.85	1.49
Endothelial Cells - Umbilical vein, donor2	11324-117E1	166.86	31.94	16.08	4.56	1.30
Endothelial Cells - Umbilical vein, donor3	11400-118D5	156.57	36.03	16.37	3.79	1.10
Endothelial Cells - Vein, donor1	11267-116G7	78.49	34.13	10.24	2.28	2.28
Endothelial Cells - Vein, donor2	11344-117G3	51.69	19.56	11.18	3.49	1.40
Endothelial Cells - Vein, donor3	11416-118F3	94.83	25.59	9.26	3.77	1.57
Eosinophils, donor1	12244-129H3	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	277.24	79.21	24.75	1.65	0.00
Eosinophils, donor3	12246-129H5	303.18	85.60	24.97	10.70	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	147.08	19.06	8.55	0.98	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	160.17	8.32	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	390.45	65.08	16.27	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	72.66	16.01	5.34	2.05	2.05
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	231.57	70.73	35.80	6.46	1.97
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	109.31	15.17	2.82	2.17	0.65
Fibroblast - Aortic Adventitial, donor1	11245-116E3	146.75	29.59	19.04	3.40	0.36
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	140.29	47.49	25.93	4.50	0.55
Fibroblast - Aortic Adventitial, donor2	11326-117E3	167.38	60.54	17.82	5.06	1.48
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	294.06	94.07	35.31	9.49	1.84
Fibroblast - Aortic Adventitial, donor3	11401-118D6	138.20	50.83	17.61	3.32	1.33
Fibroblast - Cardiac, donor1	11268-116G8	101.61	30.39	13.61	3.18	0.45
Fibroblast - Cardiac, donor2	11345-117G4	50.02	17.43	3.79	0.76	0.76
Fibroblast - Cardiac, donor3	11417-118F4	148.73	34.86	25.23	2.05	1.10
Fibroblast - Cardiac, donor4	11452-119A3	196.11	42.44	23.34	3.94	0.61
Fibroblast - Cardiac, donor5	11456-119A7	170.94	31.47	15.48	2.79	0.51
Fibroblast - Cardiac, donor6	11460-119B2	244.37	42.14	23.35	3.94	0.76
Fibroblast - Choroid Plexus, donor1	11492-119E7	215.05	36.98	10.05	3.62	2.28
Fibroblast - Choroid Plexus, donor2	11572-120E6	189.83	41.85	15.10	5.61	1.29
Fibroblast - Choroid Plexus, donor3	11653-122E6	260.73	71.77	35.16	5.86	1.46
Fibroblast - Conjunctival, donor1	11531-120A1	55.58	27.45	6.69	3.00	1.38
Fibroblast - Conjunctival, donor3	11692-122I9	265.26	77.34	14.76	11.36	2.71
Fibroblast - Dermal, donor1	11269-116G9	119.03	44.14	9.86	4.70	1.41
Fibroblast - Dermal, donor2	11346-117G5	68.87	21.70	7.55	0.94	0.47
Fibroblast - Dermal, donor3	11418-118F5	122.22	44.37	9.79	4.23	1.57
Fibroblast - Dermal, donor4	11450-119A1	59.01	18.43	3.05	2.15	0.57
Fibroblast - Dermal, donor5	11454-119A5	61.23	16.75	1.74	2.27	0.87
Fibroblast - Dermal, donor6	11458-119A9	67.41	21.44	1.62	3.74	1.46
Fibroblast - Gingival, donor1	11237-116D4	120.36	35.19	10.62	4.58	0.83
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	58.69	15.72	8.38	3.41	0.79
Fibroblast - Gingival, donor2	11318-117D4	168.55	38.48	16.87	3.43	0.92
Fibroblast - Gingival, donor3	11394-118C8	106.94	28.91	7.73	3.58	1.26
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	105.97	51.94	14.54	6.23	1.04
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	84.40	32.07	4.93	5.29	2.29
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	93.07	20.89	9.35	3.12	0.62
Fibroblast - Gingival, donor6 (control)	11922-125H5	56.12	17.44	6.36	2.43	1.22
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	12.00	8.12	0.35	0.71	1.06
Fibroblast - Gingival, donor7 (control)	11924-125H7	61.13	21.35	5.85	2.05	1.02
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	96.13	26.59	11.73	3.00	0.82
Fibroblast - Gingival, donor8 (control)	11926-125H9	62.63	18.43	8.34	3.18	0.88
Fibroblast - Gingival, donor9 (control)	11927-125I1	54.73	22.89	1.47	11.59	7.04
Fibroblast - Lung, donor1	11270-116H1	95.15	24.47	13.59	2.72	0.00
Fibroblast - Lung, donor2	11347-117G6	64.16	22.38	4.48	1.49	0.00
Fibroblast - Lung, donor3	11419-118F6	95.81	36.72	12.66	3.59	0.42
Fibroblast - Lymphatic, donor1	11506-119G3	126.62	26.66	11.66	0.83	0.83
Fibroblast - Lymphatic, donor2	11586-120G2	96.51	27.97	8.39	2.80	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	78.09	26.03	10.08	3.36	1.40
Fibroblast - Mammary, donor1	11540-120B1	119.76	39.38	9.74	3.25	1.22
Fibroblast - Mammary, donor2	11620-122A9	91.87	27.96	11.98	0.00	3.99
Fibroblast - Mammary, donor3	11701-123A9	214.43	35.74	11.91	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	126.08	32.20	10.47	1.75	1.55
Fibroblast - Periodontal Ligament, donor2	11319-117D5	72.35	22.60	5.01	1.97	0.76
Fibroblast - Periodontal Ligament, donor3	11395-118C9	81.09	22.64	5.51	2.14	0.61
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	62.59	16.79	2.67	2.67	1.53
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	73.17	24.30	6.21	4.32	1.62
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	96.37	39.55	9.74	6.61	2.90
Fibroblast - Pulmonary Artery, donor1	11250-116E8	236.98	39.35	37.91	4.53	0.44
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	388.09	67.66	51.41	6.10	1.02
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	102.90	38.76	18.04	2.67	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	152.61	43.49	9.49	3.95	0.40
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	56.95	13.89	4.76	1.98	0.99
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	53.64	27.00	3.02	3.73	3.20
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	51.05	17.15	3.74	1.38	1.18
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	82.13	28.28	6.92	3.31	1.20
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	56.57	18.89	2.70	2.70	1.19
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	28.60	10.12	1.52	1.52	1.52
Fibroblast - skin normal, donor1	11553-120C5	65.63	22.15	5.58	1.64	0.66
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	69.17	21.25	8.82	1.60	1.00
Fibroblast - skin normal, donor2	11561-120D4	42.19	11.55	3.01	1.61	0.70
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	36.57	13.30	5.14	2.42	0.30
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	56.58	15.99	3.48	4.31	2.65
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	111.97	31.28	4.44	7.01	2.74
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	61.42	19.71	3.61	0.99	2.30
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	43.99	14.06	3.20	2.13	0.96
Fibroblast - skin walker warburg, donor1	11554-120C6	70.00	18.22	4.22	1.35	0.51
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	87.66	20.23	9.57	2.35	1.10
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	265.92	66.48	44.32	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	148.16	24.40	14.82	0.87	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	274.77	39.18	43.17	1.91	0.17
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	190.76	26.54	22.64	1.56	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	140.28	24.27	19.93	1.28	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	199.81	39.81	16.84	6.89	1.53
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	238.64	40.20	33.82	5.74	1.28
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	207.67	56.48	24.82	6.28	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	193.86	87.42	13.24	11.58	0.83
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	122.61	49.32	10.96	8.45	1.14
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	171.98	50.52	16.84	3.96	0.99
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	183.71	72.43	14.01	12.69	1.85
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	123.28	48.60	12.72	6.20	0.98
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	164.06	39.36	15.04	6.19	0.88
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	181.60	60.49	19.22	5.51	0.71
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	150.11	48.89	14.41	6.03	0.86
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	175.41	57.75	22.56	4.30	0.27
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	92.92	47.95	10.28	5.33	0.62
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	124.31	44.99	10.94	3.46	0.69
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	144.35	44.73	14.03	1.83	0.20
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	172.73	60.01	17.80	5.25	0.91
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	135.78	53.56	14.08	5.73	0.62
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	137.48	48.31	12.24	3.72	0.22
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	171.97	63.82	15.66	5.91	1.18
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	145.61	49.91	12.88	5.56	0.64
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	168.91	57.20	14.75	4.92	0.67
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	144.17	55.65	9.68	6.45	0.60
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	143.52	55.30	13.40	5.26	1.02
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	175.30	55.60	19.24	4.43	0.71
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	137.25	59.42	7.28	5.62	1.04
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	132.69	58.41	9.22	2.90	1.37
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	150.82	58.43	15.60	6.64	1.77
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	155.16	56.24	14.64	4.74	0.92
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	142.11	54.31	14.91	4.08	1.23
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	194.55	75.10	15.27	6.60	1.03
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	144.35	61.68	12.57	7.26	1.27
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	153.92	58.87	17.01	4.84	1.17
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	169.73	62.82	13.23	6.17	0.88
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	195.31	71.21	11.56	7.99	1.35
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	126.76	47.82	15.56	6.00	1.95
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	225.46	73.76	10.58	8.02	2.25
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	135.78	59.98	10.42	5.12	1.42
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	145.84	57.10	14.71	3.80	0.95
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	202.52	76.93	18.25	5.78	0.91
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	151.69	63.45	14.53	8.68	0.73
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	174.99	73.77	19.76	3.95	0.88
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	182.92	71.26	16.83	4.77	1.12
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	137.21	51.85	17.68	2.59	0.56
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	194.40	73.00	32.36	4.55	1.34
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	172.59	64.11	24.94	4.13	0.92
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	140.03	54.02	19.56	4.02	0.65
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	198.70	72.65	29.55	3.80	2.17
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	186.93	68.95	22.12	5.53	1.66
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	191.90	61.19	17.55	4.39	1.54
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	152.73	53.55	15.87	3.97	0.99
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	176.50	55.80	16.75	4.88	1.32
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	168.67	57.30	17.55	6.05	2.02
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	130.89	43.72	9.91	2.54	1.27
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	225.73	53.95	18.51	7.17	1.19
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	192.29	65.33	22.50	4.78	0.15
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	195.58	57.90	24.14	5.52	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	179.93	39.74	18.46	4.07	1.25
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	176.31	45.21	15.54	2.83	1.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	142.51	29.52	10.15	0.46	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	136.11	27.22	17.32	2.47	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	172.13	41.00	21.27	5.80	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	247.09	65.78	22.46	3.21	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	180.84	27.82	27.82	5.22	3.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	207.98	41.66	14.65	2.93	1.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	199.72	44.06	17.71	4.94	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	133.29	26.66	19.99	6.66	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	193.80	39.99	13.70	4.75	0.56
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	183.69	41.51	12.42	4.25	1.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	108.21	26.00	8.39	5.03	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	194.98	54.39	15.90	6.04	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	182.40	43.14	18.00	6.45	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	279.81	48.03	10.44	14.62	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	221.63	61.28	13.74	13.74	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	184.40	48.84	13.62	6.81	0.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	176.19	37.27	20.33	6.78	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	212.49	58.40	15.74	9.11	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	157.18	41.19	14.73	5.29	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	205.47	68.49	31.61	10.54	10.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	191.05	50.36	15.76	5.00	1.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	194.28	53.13	16.30	6.52	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	226.07	58.86	13.38	8.03	0.67
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	246.57	68.96	16.95	10.40	1.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	185.89	53.06	14.04	7.19	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	166.48	54.67	0.00	7.45	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	239.23	48.60	10.38	9.91	0.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	243.81	64.57	12.67	9.05	1.81
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	219.24	54.43	11.70	9.16	1.53
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	242.89	61.42	16.35	7.18	0.80
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	259.51	61.18	18.75	10.36	0.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	283.31	68.47	9.44	9.44	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	242.71	57.18	17.50	10.50	2.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	250.16	64.08	12.29	10.09	0.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	210.23	44.08	14.41	11.02	1.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	207.13	63.27	23.28	5.97	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	209.14	51.92	19.41	7.76	1.94
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	49.08	12.55	2.28	2.28	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	39.50	15.39	2.49	3.33	1.25
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	32.61	7.87	3.37	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	98.00	25.06	6.34	1.59	4.76
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	181.30	53.89	13.37	7.52	2.51
Hep-2 cells mock treated, biol_rep1	11898-125E8	112.44	24.02	16.13	2.67	0.12
Hep-2 cells mock treated, biol_rep2	11899-125E9	104.83	24.31	13.67	1.69	0.00
Hep-2 cells mock treated, biol_rep3	11900-125F1	102.15	25.25	13.88	1.14	0.23
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	122.21	26.67	18.47	1.64	0.11
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	104.45	23.21	12.68	2.58	0.21
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	83.53	25.62	13.78	1.51	0.22
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	138.98	31.51	17.31	1.62	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	128.83	26.59	15.44	1.03	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	115.33	27.87	15.38	2.56	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	186.35	54.28	18.47	7.28	2.24
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	74.87	30.73	5.63	1.73	0.87
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	444.16	44.94	52.88	0.00	5.29
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	142.50	45.15	16.93	2.82	0.71
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	162.74	46.50	16.71	3.63	0.73
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	139.52	26.93	16.43	2.45	0.70
Hepatocyte, donor1	11523-119I2	128.32	29.05	15.74	0.00	0.00
Hepatocyte, donor2	11603-120I1	150.83	23.70	20.47	0.00	0.00
Hepatocyte, donor3	11684-122I1	134.36	33.13	9.82	2.45	1.23
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	35.25	15.01	0.65	3.26	1.31
Intestinal epithelial cells (polarized), donor1	11246-116E4	232.81	32.86	21.50	0.70	0.35
Iris Pigment Epithelial Cells, donor1	11530-119I9	392.82	91.65	62.15	5.35	1.37
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	3.18	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	0.00	13.35	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	4.15	5.54	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	10.01	7.51	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	0.00	11.87	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	10.25	5.13	0.00	2.56	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	9.14	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	14.62	8.12	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	5.00	3.33	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	14.52	10.89	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	0.00	3.97	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	5.54	5.54	0.00	0.00	1.11
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	15.71	10.48	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	6.30	5.04	1.26	0.63	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	6.19	9.28	0.00	1.55	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	14.63	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	9.04	2.58	0.00	0.00	0.65
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	4.83	6.44	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	0.00	23.90	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	7.33	3.26	0.81	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	5.88	2.10	0.00	0.42	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	7.23	5.63	0.80	0.80	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	12.00	1.85	0.00	0.92	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	5.19	6.14	0.94	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	6.35	5.44	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	2.15	5.38	0.00	1.08	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	2.54	5.08	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	32.86	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	4.46	3.19	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	10.94	5.47	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	15.80	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	10.71	2.14	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	6.64	3.32	3.32	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	20.85	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	7.41	4.94	0.62	0.31	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	7.02	3.51	1.76	0.00	1.76
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	6.29	0.00	0.00	0.00	3.14
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	11.13	3.48	2.09	0.70	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	8.85	2.21	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	9.73	6.48	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	8.72	7.85	0.87	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	4.50	6.75	0.00	2.25	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	13.94	3.48	3.48	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	4.27	5.33	1.07	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	9.70	2.77	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	11.40	5.70	0.00	2.85	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	10.12	1.84	0.92	0.92	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	18.15	3.03	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	12.42	18.63	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	9.52	6.34	1.06	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	133.74	15.99	15.67	0.65	0.00
Keratinocyte - epidermal, donor2	11349-117G8	83.75	7.03	11.13	0.59	0.00
Keratinocyte - epidermal, donor3	11421-118F8	214.02	21.30	24.71	1.14	0.09
Keratinocyte - oral, donor1	11251-116E9	277.21	25.20	15.78	2.61	0.45
Keratocytes, donor1	11527-119I6	56.73	31.29	7.91	3.09	1.38
Keratocytes, donor2	11607-120I5	86.71	23.44	9.37	3.52	1.17
Keratocytes, donor3	11688-122I5	66.00	31.22	4.54	4.74	1.38
Krukenberg tumor cell line:HSKTC	10687-109F3	134.07	21.98	8.79	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	276.16	39.91	32.36	6.47	1.08
Lens Epithelial Cells, donor2	11609-120I7	296.52	123.52	20.76	11.19	3.00
Lens Epithelial Cells, donor3	11690-122I7	322.41	65.39	43.59	6.26	1.41
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	157.35	49.33	18.85	6.17	1.07
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	142.05	48.56	20.37	4.47	1.40
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	164.81	48.64	18.42	6.14	1.57
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	146.26	48.93	13.44	6.99	0.54
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	161.68	43.18	20.17	4.41	1.26
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	162.58	43.88	18.98	4.42	1.29
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	131.33	37.35	13.13	5.75	0.41
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	183.80	57.64	26.55	4.55	2.02
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	155.53	50.67	18.44	4.08	1.41
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	153.47	40.74	13.84	5.93	1.58
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	172.94	47.50	26.56	4.27	1.16
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	161.26	43.32	22.22	5.74	0.93
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	132.05	44.25	19.16	2.79	1.05
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	152.66	43.65	16.22	5.01	1.67
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	161.66	47.11	24.45	6.04	2.75
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	148.13	45.27	17.55	4.93	1.85
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	164.60	50.19	15.28	4.05	2.18
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	157.19	51.79	15.19	4.76	2.38
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	130.33	35.87	17.44	2.96	0.33
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	170.45	54.47	22.55	6.15	0.88
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	162.30	49.04	17.92	4.23	1.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	140.64	45.59	15.52	1.94	0.48
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	162.12	52.78	19.93	4.58	1.35
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	163.19	47.38	18.77	5.60	1.51
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	146.71	47.18	16.07	4.15	2.59
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	164.79	48.37	20.73	5.65	1.05
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	145.41	48.27	20.75	3.01	1.95
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	177.47	48.84	22.70	3.44	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	168.39	52.31	22.20	4.33	0.75
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	147.49	42.09	16.96	4.77	1.38
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	120.66	37.80	14.05	3.39	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	149.52	48.96	22.49	3.31	0.66
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	156.10	50.55	22.67	5.08	1.12
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	174.00	48.50	28.88	4.07	1.85
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	170.24	42.75	21.25	3.71	1.98
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	142.99	43.45	18.97	3.71	0.96
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	127.69	40.53	14.15	3.22	0.96
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	163.42	49.61	22.52	4.56	0.61
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	172.86	56.41	23.79	5.18	1.40
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	150.76	44.80	16.36	3.20	2.84
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	172.10	57.20	17.94	5.82	0.48
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	156.54	47.93	21.94	5.91	1.09
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	167.95	42.26	20.05	3.94	1.07
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	169.54	47.37	19.60	6.86	1.63
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	163.85	48.03	21.89	6.83	0.94
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	153.20	50.99	18.93	3.47	0.62
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	144.97	42.52	23.56	5.38	1.02
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	149.78	43.56	16.11	2.69	1.49
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	92.91	6.80	4.53	2.27	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	102.03	33.75	4.60	2.30	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	104.65	37.85	7.42	2.97	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	118.05	27.08	10.16	2.12	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	124.49	23.91	6.33	1.41	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	131.69	32.69	9.34	1.87	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	106.66	24.22	7.21	1.03	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	109.43	32.12	9.52	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	122.37	27.60	9.05	0.68	0.23
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	136.69	33.74	13.38	0.58	0.29
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	136.40	29.71	7.65	1.35	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	109.88	29.40	9.35	1.76	0.27
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	92.43	27.73	9.76	2.57	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	116.09	27.88	12.00	1.41	0.35
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	126.60	32.65	9.99	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	119.71	27.51	7.13	0.51	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	131.00	30.42	10.94	1.60	0.53
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	146.05	32.69	12.66	1.51	0.19
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	112.28	32.52	10.43	3.07	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	119.87	31.80	7.34	2.45	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	132.86	31.03	12.29	2.92	0.21
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	143.21	31.67	15.41	0.56	0.84
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	86.55	26.79	8.24	1.03	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	132.09	29.90	7.26	0.87	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	132.43	31.09	7.47	1.20	0.30
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	131.68	30.43	7.75	0.55	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	106.75	20.15	5.66	1.06	0.35
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	104.73	26.92	12.17	1.84	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	105.92	26.48	2.30	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	97.47	23.41	4.61	0.77	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	97.37	22.08	12.45	0.00	0.57
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	116.51	27.90	8.20	0.82	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	100.77	25.31	8.13	1.36	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	105.57	15.80	8.62	1.44	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	135.19	29.88	8.22	2.24	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	88.07	21.55	4.83	0.37	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	98.64	29.29	10.77	1.72	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	115.60	28.26	9.42	1.71	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	121.28	24.66	9.33	1.67	1.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	118.85	21.12	10.26	0.60	0.60
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	111.63	22.04	3.55	0.71	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	106.21	26.12	10.66	0.69	0.34
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	104.67	27.37	7.51	0.54	0.54
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	92.25	26.93	5.39	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	122.98	27.78	6.30	1.48	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	138.39	30.24	10.47	2.33	1.16
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	106.83	22.21	9.52	1.06	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	98.84	27.61	7.20	0.80	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	86.50	30.53	6.54	1.45	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	107.31	29.89	10.73	1.53	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	126.28	29.60	10.36	0.49	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	86.57	22.58	15.05	0.00	0.94
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	110.12	28.66	6.54	2.51	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	108.15	30.64	8.56	0.00	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	80.89	22.37	15.49	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	107.33	28.95	10.69	2.23	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	93.46	29.72	7.04	0.39	0.39
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	89.06	21.77	8.58	1.98	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	107.42	28.54	7.26	0.52	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	104.58	19.25	3.94	1.31	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	88.34	25.16	9.50	2.24	1.12
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	98.93	30.03	10.60	1.32	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	115.33	22.37	8.49	1.16	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	81.52	24.81	5.06	1.52	0.51
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	93.24	21.15	7.69	0.96	0.48
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	104.55	24.65	7.55	0.80	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	98.43	20.05	8.51	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	107.21	13.83	6.23	1.38	0.69
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	91.58	18.24	6.46	1.14	0.38
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	95.54	26.34	5.68	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	93.12	15.72	5.44	1.81	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	97.29	25.67	7.61	1.90	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	76.76	20.26	3.73	0.53	0.53
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	109.19	12.07	5.75	0.57	0.57
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	90.51	23.65	5.66	1.03	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	80.64	25.46	9.20	1.41	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	110.09	19.86	6.24	1.13	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	97.35	21.63	8.74	2.50	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	90.83	27.41	10.96	1.57	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	103.97	20.88	7.10	3.34	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	103.61	19.98	6.04	0.93	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	89.65	20.74	7.36	1.34	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	116.02	18.71	4.28	1.60	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	99.00	22.63	10.10	0.40	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	83.52	15.60	6.42	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	100.47	12.45	8.00	1.78	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	98.02	25.64	8.55	2.28	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	87.43	15.34	9.20	1.53	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	108.34	16.96	7.11	0.55	0.55
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	85.53	16.93	7.57	0.45	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	89.68	19.50	9.62	2.34	0.26
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	122.67	23.87	5.97	1.99	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	68.59	41.57	2.08	0.00	2.08
Macrophage - monocyte derived, donor1	11232-116C8	1341.28	490.25	141.76	24.16	2.73
Macrophage - monocyte derived, donor2	11313-117C8	545.02	231.77	64.04	11.56	3.12
Macrophage - monocyte derived, donor3	11389-118C3	906.95	308.83	110.24	15.47	3.54
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	303.74	43.01	54.70	4.78	0.00
Mallassez-derived cells, donor2	11929-125I3	256.38	29.47	37.87	1.58	0.16
Mallassez-derived cells, donor3	11930-125I4	198.06	17.65	21.27	1.81	0.28
Mammary Epithelial Cell, donor1	11273-116H4	106.72	19.73	17.84	1.30	0.00
Mammary Epithelial Cell, donor2	11350-117G9	160.41	17.08	15.93	1.16	0.00
Mammary Epithelial Cell, donor3	11422-118F9	174.85	14.97	19.46	1.50	0.00
Mast cell - stimulated, donor1	11487-119E2	77.28	50.17	8.14	6.78	0.00
Mast cell, donor1	11563-120D6	166.97	120.14	16.33	9.84	2.38
Mast cell, donor2	11565-120D8	221.69	104.90	23.48	9.51	2.67
Mast cell, donor3	11566-120D9	205.31	108.06	19.59	7.20	2.03
Mast cell, donor4	11567-120E1	297.14	107.26	28.90	7.80	2.48
Mast cell, expanded and stimulated, donor5	11940-126A5	167.12	104.57	16.08	5.99	2.88
Mast cell, expanded and stimulated, donor8	11942-126A7	86.39	51.36	8.17	5.25	3.50
Mast cell, expanded, donor5	11939-126A4	320.65	196.98	30.40	12.96	5.74
Mast cell, expanded, donor8	11941-126A6	145.44	73.98	9.87	7.87	2.51
Melanocyte - dark, donor1	11502-119F8	149.45	41.19	14.23	2.29	0.10
Melanocyte - dark, donor2	11582-120F7	301.44	47.41	46.72	1.04	0.35
Melanocyte - dark, donor3	11663-122F7	283.97	93.45	42.02	2.97	2.03
Melanocyte - light, donor1	11274-116H5	141.51	48.66	25.39	1.41	2.12
Melanocyte - light, donor2	11351-117H1	180.17	66.20	37.54	2.73	1.36
Melanocyte - light, donor3	11423-118G1	149.16	48.56	23.42	1.73	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	228.66	65.91	30.20	1.77	1.04
Melanocyte, donor2 (MC+2)	12739-135I3	360.65	74.77	73.15	2.42	0.81
Melanocyte, donor3 (MC+3)	12837-137B2	270.27	83.30	34.55	2.95	0.27
Meningeal Cells, donor1	11493-119E8	169.84	43.79	17.74	3.85	1.36
Meningeal Cells, donor2	11573-120E7	498.25	99.91	46.22	11.00	1.32
Meningeal Cells, donor3	11654-122E7	147.76	39.69	15.89	3.59	1.71
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	122.33	37.07	13.12	3.14	0.57
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	367.91	75.57	66.52	6.04	1.51
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	57.82	15.77	3.94	2.63	3.94
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	94.19	26.16	10.47	1.31	2.62
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	161.46	31.57	20.81	3.59	0.72
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	460.81	99.11	62.90	6.99	1.06
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	367.94	77.41	46.75	5.03	0.50
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	102.19	31.86	14.06	1.98	1.54
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	81.83	23.38	7.31	0.73	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	64.86	25.17	6.34	2.46	0.82
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	208.18	46.95	8.59	6.79	5.68
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	82.52	36.43	9.66	1.49	2.97
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	149.73	40.52	11.97	3.42	1.45
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	80.71	16.32	3.26	4.45	0.59
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	37.37	18.68	2.34	4.67	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	104.39	29.46	8.33	1.28	1.28
Mesenchymal stem cells - adipose, donor0	11217-116B2	161.98	45.01	25.87	2.48	1.06
Mesenchymal stem cells - hepatic, donor0	11218-116B3	146.67	29.40	9.38	3.13	0.31
Mesenchymal stem cells - umbilical, donor0	11214-116A8	99.42	23.95	10.89	2.18	0.00
Mesothelial Cells, donor1	11247-116E5	365.15	108.72	53.30	5.30	1.59
Mesothelial Cells, donor2	12156-128G5	508.47	100.59	111.10	6.01	2.00
Mesothelial Cells, donor3	11402-118D7	209.71	54.05	28.83	4.05	1.45
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	414.55	110.73	48.61	5.40	1.35
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	1222.01	360.05	141.61	19.46	4.19
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	557.70	241.75	65.96	19.43	3.53
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	134.83	51.86	10.37	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	1232.35	351.17	142.27	14.26	2.48
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	561.52	230.87	76.34	10.58	2.49
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	171.39	48.64	13.90	4.63	4.63
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	1143.20	381.15	120.38	16.77	4.25
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	595.35	230.88	79.13	19.08	4.65
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	233.59	19.47	38.93	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	1139.43	343.84	121.32	16.05	4.88
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	492.97	215.80	71.67	16.23	4.36
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	111.17	34.21	25.65	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	1297.32	323.00	129.20	17.70	3.54
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	798.63	316.49	100.30	14.82	5.32
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	171.07	44.74	27.63	6.58	1.32
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	1224.96	359.51	131.58	14.86	4.24
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	246.78	82.87	26.70	5.52	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	815.78	222.35	87.33	11.03	2.98
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	191.14	77.13	16.77	13.41	3.35
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	33.95	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	1198.31	349.76	134.23	18.57	2.26
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	477.95	212.47	60.84	16.64	1.66
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	202.91	49.21	26.54	4.42	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	1059.13	263.86	122.72	9.21	2.07
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	583.48	239.37	84.98	19.98	1.89
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	637.57	203.42	76.44	13.05	2.04
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	1129.55	335.97	143.31	9.23	1.93
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	431.47	163.38	58.68	15.34	3.11
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	123.82	10.32	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	796.56	245.08	84.54	8.98	1.75
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	302.65	110.01	37.51	12.67	1.01
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	159.07	43.08	18.23	3.31	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	883.32	214.99	101.92	10.33	4.62
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	443.48	181.15	57.93	15.59	1.76
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	146.10	38.16	8.72	0.00	1.09
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	895.75	262.38	112.45	15.38	3.84
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	483.88	205.72	72.44	14.81	3.20
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	244.08	78.16	9.60	6.86	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	918.56	268.31	120.14	11.01	3.50
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	1104.83	350.31	107.79	26.95	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	277.24	85.62	12.23	10.19	6.12
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	948.98	291.22	119.11	16.64	4.82
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	146.79	58.49	12.14	8.83	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	153.69	58.28	16.65	4.48	3.20
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	938.62	293.29	110.08	12.40	4.46
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	275.57	105.78	22.27	10.44	2.09
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	174.58	72.93	17.68	4.42	2.21
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	866.31	320.34	109.06	15.73	4.44
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	232.81	82.71	18.38	8.75	0.88
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	194.24	76.70	21.66	8.88	0.71
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	826.50	295.14	98.47	15.99	3.37
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	279.30	99.34	39.90	9.14	1.25
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	128.20	69.35	16.32	5.24	1.17
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	485.68	173.76	52.19	10.26	1.21
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	429.91	206.61	59.27	9.60	0.83
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	108.28	43.31	0.00	7.22	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	474.71	140.38	46.18	9.24	2.77
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	381.88	187.81	51.79	9.68	1.71
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	247.07	147.85	35.79	10.64	0.97
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	493.68	223.13	68.42	5.96	2.85
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	391.66	218.35	52.76	11.15	4.29
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	116.88	57.80	10.16	4.45	0.64
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	290.64	137.18	34.70	5.07	1.87
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	478.63	278.38	58.97	18.56	2.10
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	202.42	120.63	30.09	8.19	1.84
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	474.27	241.75	62.43	8.60	5.10
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	413.74	227.76	51.30	15.04	2.65
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	180.50	97.45	24.27	10.62	1.14
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	420.76	207.97	64.21	9.09	4.26
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	520.86	335.77	72.51	17.94	3.20
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	150.54	76.90	17.60	4.56	1.96
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	361.07	185.83	42.93	10.88	2.65
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	401.64	281.41	57.38	19.03	3.46
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	422.86	201.95	45.75	7.01	3.71
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	369.25	197.13	51.22	6.85	4.17
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	2324.16	655.44	244.85	26.37	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	1630.76	527.55	140.80	14.26	5.35
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	1535.09	483.33	144.57	16.43	5.26
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	1293.90	350.30	135.70	7.36	3.16
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	1874.27	533.36	189.19	18.98	3.76
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	1134.35	379.98	101.51	19.56	2.79
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	1471.70	616.99	117.92	23.66	6.76
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	1064.84	374.48	118.26	10.65	2.40
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	1434.12	406.60	172.93	14.82	3.73
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	1286.32	432.46	123.77	14.00	3.68
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	1153.50	397.94	109.19	13.19	4.03
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	1106.03	290.90	119.78	9.33	3.11
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	2351.53	641.86	293.94	20.31	4.28
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	1541.70	506.17	127.51	15.46	3.86
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	1159.41	379.74	125.23	15.15	4.04
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	1333.65	368.09	141.67	17.29	2.53
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	2896.85	792.65	354.11	29.96	5.45
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	3457.45	1168.59	391.65	48.32	8.27
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	3666.94	1087.61	448.65	35.63	8.10
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	1705.28	596.62	209.95	24.17	6.04
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	296.93	68.52	11.42	5.71	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	1119.02	463.27	127.24	26.10	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	575.05	204.36	66.53	0.00	9.50
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	276.08	87.84	25.10	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	172.35	56.44	20.90	4.09	1.72
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	106.61	44.42	4.70	5.23	3.14
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	121.48	82.77	10.01	4.67	2.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	100.17	54.68	10.43	1.67	0.83
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	156.30	65.98	14.45	7.99	1.52
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	94.16	15.96	4.79	6.38	1.60
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	101.31	63.23	7.48	1.36	0.68
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	134.15	44.10	14.70	11.03	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	113.84	67.80	9.63	5.86	1.26
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	164.10	85.30	12.55	8.14	0.93
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	134.57	91.61	14.32	14.86	3.24
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	105.96	51.09	10.72	5.47	2.73
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	512.20	133.62	33.40	11.13	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	152.38	95.30	17.37	5.96	1.99
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	248.75	97.71	23.28	12.18	1.62
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	208.09	95.89	21.31	9.52	1.81
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	142.56	88.67	9.31	13.88	3.27
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	187.36	76.73	19.87	8.38	4.01
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	226.50	137.91	18.57	11.67	4.24
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	156.08	93.65	9.00	9.00	4.20
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	511.96	158.18	41.68	27.57	4.59
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	204.58	101.31	20.33	9.76	1.46
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	229.47	82.19	20.11	9.52	2.65
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	213.78	116.74	13.36	9.85	4.22
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	181.13	96.54	13.79	11.49	5.52
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	193.45	83.87	13.82	9.96	4.82
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	624.25	159.34	48.97	30.01	2.41
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	351.45	85.97	20.23	15.17	2.53
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	230.80	63.72	18.05	10.25	3.56
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	156.65	91.88	13.13	11.01	4.23
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	202.22	109.89	11.63	11.16	3.56
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	172.99	78.12	14.17	7.30	2.15
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	677.08	144.44	54.17	9.03	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	172.61	83.97	11.33	15.33	5.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	131.65	31.11	13.08	5.41	2.25
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	145.23	60.31	16.67	5.56	1.98
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	156.94	101.22	7.43	10.22	10.22
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	250.86	68.86	22.70	8.32	4.16
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	116.99	45.95	6.84	6.52	1.96
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	139.02	67.55	6.54	20.48	10.46
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	168.70	32.56	15.38	4.98	2.26
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	184.32	67.91	7.94	7.06	3.53
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	159.56	74.46	13.96	9.31	5.98
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	277.78	107.64	12.40	16.87	10.42
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	136.67	42.88	7.27	4.98	2.68
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	293.37	91.04	22.99	16.03	3.93
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	158.25	37.57	16.58	5.08	2.65
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	210.07	50.15	15.59	9.49	4.74
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	418.98	61.31	20.44	5.11	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	243.87	88.40	17.68	10.36	6.10
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	107.95	40.92	6.61	3.78	1.89
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	188.55	76.27	12.71	21.49	4.84
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	193.83	55.38	13.45	7.12	3.16
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	523.74	85.02	39.68	17.00	4.53
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	364.17	65.75	45.52	5.06	0.00
Myoblast, donor1	11241-116D8	111.68	26.09	20.37	2.36	0.87
Myoblast, donor2	11322-117D8	163.60	37.40	28.19	6.52	0.77
Myoblast, donor3	11398-118D3	97.70	35.82	20.18	2.69	1.01
NK T cell leukemia cell line:KHYG-1	10777-110G3	78.07	35.02	0.88	2.33	0.29
Natural Killer Cells, donor1	11230-116C6	53.51	18.45	0.62	4.00	0.62
Natural Killer Cells, donor2	11311-117C6	31.06	17.79	0.90	1.81	0.30
Natural Killer Cells, donor3	11387-118C1	38.65	18.04	1.66	1.47	0.92
Neural stem cells, donor1	11275-116H6	29.04	22.87	1.45	5.08	2.18
Neural stem cells, donor2	11352-117H2	11.55	13.48	0.00	1.93	1.93
Neurons, donor1	11494-119E9	27.31	20.48	3.41	1.14	1.14
Neurons, donor2	11574-120E8	46.67	24.00	4.62	3.30	3.52
Neurons, donor3	11655-122E8	23.02	10.69	1.64	6.58	4.11
Neutrophils, donor1	11233-116C9	154.98	47.33	3.71	2.78	0.00
Neutrophils, donor2	11314-117C9	118.85	31.89	11.60	2.90	0.00
Neutrophils, donor3	11390-118C4	91.02	49.48	4.89	1.22	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	132.63	35.62	7.24	4.04	1.42
Nucleus Pulposus Cell, donor2	11409-118E5	201.55	58.93	24.75	8.14	2.93
Nucleus Pulposus Cell, donor3	11462-119B4	194.13	44.92	11.43	7.82	1.80
Olfactory epithelial cells, donor1	11933-125I7	80.39	17.89	5.64	1.93	0.55
Olfactory epithelial cells, donor2	11934-125I8	76.86	13.61	5.50	1.45	0.43
Olfactory epithelial cells, donor3	11935-125I9	104.20	17.48	8.17	2.84	0.45
Olfactory epithelial cells, donor4	11936-126A1	118.44	22.89	7.40	3.70	1.36
Oligodendrocyte - precursors, donor1	11496-119F2	337.02	44.53	26.48	4.81	1.20
Osteoblast - differentiated, donor1	11276-116H7	111.66	27.01	7.23	5.74	4.25
Osteoblast - differentiated, donor2	11353-117H3	357.79	74.30	54.87	12.57	1.14
Osteoblast - differentiated, donor3	11425-118G3	233.39	44.07	16.14	12.41	2.48
Osteoblast, donor1	11277-116H8	41.04	16.81	3.13	1.37	1.17
Osteoblast, donor2	11354-117H4	54.08	22.47	4.21	1.40	0.00
Osteoblast, donor3	11426-118G4	52.96	17.06	5.69	2.67	0.89
Pancreatic stromal cells, donor1	11249-116E7	174.87	61.07	20.89	5.31	1.35
Pericytes, donor1	11491-119E6	216.41	44.28	17.91	7.45	1.89
Pericytes, donor2	11571-120E5	149.18	49.12	5.66	14.03	5.21
Pericytes, donor3	11652-122E5	108.85	29.30	7.73	3.05	1.42
Perineurial Cells, donor1	11499-119F5	107.94	26.56	5.43	3.50	2.37
Perineurial Cells, donor2	11579-120F4	255.88	46.47	35.88	3.77	0.37
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	186.46	54.82	7.65	6.37	0.96
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	197.36	55.58	16.41	4.16	0.49
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	133.43	43.35	7.38	3.49	1.04
Placental Epithelial Cells, donor1	11278-116H9	274.56	51.90	60.99	4.07	0.48
Placental Epithelial Cells, donor2	11355-117H5	288.31	29.94	26.61	2.22	1.11
Placental Epithelial Cells, donor3	11427-118G5	276.82	31.41	22.38	2.94	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	153.48	54.11	14.87	1.90	1.90
Preadipocyte - breast, donor1	11467-119B9	162.64	40.33	23.45	3.75	1.88
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	86.15	24.67	12.66	2.48	0.65
Preadipocyte - breast, donor2	11328-117E5	139.37	37.37	13.06	3.83	2.03
Preadipocyte - omental, donor1	11468-119C1	229.74	69.90	33.89	5.86	2.66
Preadipocyte - omental, donor2	11329-117E6	133.12	39.72	14.40	3.49	0.00
Preadipocyte - omental, donor3	11403-118D8	130.07	46.13	17.33	4.01	1.58
Preadipocyte - perirenal, donor1	11469-119C2	208.66	41.34	25.59	4.92	2.95
Preadipocyte - subcutaneous, donor1	11279-116I1	29.18	11.06	8.29	1.54	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	35.59	15.76	4.96	0.53	0.35
Preadipocyte - subcutaneous, donor3	11428-118G6	73.05	27.25	11.07	4.60	2.38
Preadipocyte - visceral, donor1	11280-116I2	56.35	25.71	7.73	2.98	0.84
Preadipocyte - visceral, donor2	11357-117H7	89.27	37.27	11.96	3.68	1.38
Preadipocyte - visceral, donor3	11429-118G7	63.63	22.88	4.60	2.82	0.63
Prostate Epithelial Cells (polarized), donor1	11253-116F2	202.14	25.19	13.73	0.91	0.15
Prostate Epithelial Cells, donor2	11331-117E8	152.07	27.35	27.76	1.76	0.41
Prostate Epithelial Cells, donor3	11404-118D9	122.90	21.68	8.82	1.29	0.31
Prostate Stromal Cells, donor1	11254-116F3	110.71	34.17	16.29	4.21	1.03
Prostate Stromal Cells, donor2	11332-117E9	100.77	41.96	9.50	4.66	1.08
Prostate Stromal Cells, donor3	11405-118E1	151.83	68.20	17.62	7.61	1.46
Renal Cortical Epithelial Cells, donor1	11516-119H4	172.27	44.89	14.60	2.55	1.09
Renal Cortical Epithelial Cells, donor2	11596-120H3	211.89	48.45	22.60	2.50	0.62
Renal Epithelial Cells, donor1	11517-119H5	70.00	17.75	8.62	0.51	0.00
Renal Epithelial Cells, donor2	11597-120H4	145.11	27.03	19.92	4.98	0.00
Renal Epithelial Cells, donor3	11678-122H4	221.26	45.31	25.09	3.18	0.53
Renal Glomerular Endothelial Cells, donor1	11514-119H2	144.34	32.00	14.30	2.72	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	198.78	43.80	24.66	6.47	1.08
Renal Glomerular Endothelial Cells, donor3	11675-122H1	124.10	25.53	14.87	3.33	0.44
Renal Glomerular Endothelial Cells, donor4	11783-124B1	54.57	23.96	3.99	2.00	0.67
Renal Mesangial Cells, donor1	11518-119H6	178.05	44.46	20.69	3.30	1.54
Renal Mesangial Cells, donor2	11598-120H5	174.30	43.26	11.91	1.25	0.00
Renal Mesangial Cells, donor3	11679-122H5	143.14	37.45	17.48	3.61	0.83
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	137.97	34.63	12.08	1.61	0.27
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	112.17	31.21	12.65	1.69	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	148.88	40.50	11.19	3.09	0.58
Retinal Pigment Epithelial Cells, donor0	11215-116A9	317.10	72.34	49.26	5.44	1.04
Retinal Pigment Epithelial Cells, donor1	11528-119I7	299.88	80.73	33.83	3.70	0.28
Retinal Pigment Epithelial Cells, donor2	11608-120I6	189.36	49.40	34.99	3.09	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	203.74	60.97	29.11	3.76	0.50
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	218.09	51.98	13.63	5.88	2.14
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	153.67	92.91	13.40	8.93	7.15
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	259.22	155.75	24.77	10.46	5.50
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	146.75	103.83	14.50	11.02	3.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	44.99	22.75	3.90	4.68	1.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	44.39	30.59	3.18	5.76	1.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	62.46	44.28	6.80	5.58	1.78
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	64.01	38.70	4.47	6.45	2.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	48.25	36.01	5.48	5.24	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	73.96	41.83	7.40	5.32	2.08
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	43.54	27.24	4.24	3.97	1.92
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	52.64	32.07	5.60	4.99	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	62.36	35.12	6.45	5.20	1.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	59.96	27.54	3.16	4.59	2.01
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	55.37	34.23	5.69	5.58	0.97
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	63.06	43.37	4.87	5.53	1.77
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	47.60	25.24	3.25	3.06	1.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	45.84	28.97	4.47	4.29	1.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	56.18	37.21	4.70	5.45	1.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	48.44	25.48	2.65	4.51	1.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	40.20	29.69	3.60	3.70	0.97
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	59.20	41.44	4.58	5.54	0.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	47.20	28.73	2.46	3.31	0.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	47.93	30.55	3.08	6.73	2.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	51.10	31.45	3.93	4.27	1.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	44.31	26.98	3.10	4.01	1.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	42.19	29.92	3.68	4.66	1.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	51.71	33.98	3.76	5.51	1.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	63.69	27.60	4.25	4.01	2.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	54.76	39.29	2.58	5.95	1.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	59.86	44.66	6.08	8.42	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	58.27	25.30	2.70	3.94	1.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	52.21	34.95	3.98	5.09	1.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	43.45	34.88	5.22	4.18	0.63
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	47.24	29.20	4.31	5.25	1.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	47.00	23.84	3.58	4.94	1.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	51.48	32.78	5.01	4.63	1.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	56.91	26.82	4.30	3.95	1.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	33.61	29.35	3.29	4.53	1.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	50.89	41.04	4.10	4.93	1.97
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	51.47	23.35	3.24	3.24	1.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	41.43	32.85	5.18	4.29	1.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	50.11	30.65	5.06	6.13	0.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	76.60	48.67	4.98	10.65	3.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	56.43	56.19	7.62	5.24	1.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	70.14	50.59	6.45	6.25	2.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	90.60	53.87	5.84	7.35	3.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	99.92	79.31	10.83	11.18	3.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	113.93	69.51	9.97	10.88	4.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	126.79	65.60	11.38	11.50	4.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	118.92	72.78	13.39	9.17	2.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	185.57	111.95	16.43	11.56	3.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	136.84	68.12	9.04	9.04	3.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	144.53	122.37	17.42	13.80	4.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	164.45	115.02	20.97	13.18	5.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	162.47	116.66	15.23	14.29	6.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	129.56	106.94	14.73	14.73	6.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	141.83	81.13	16.23	6.61	1.80
Schwann Cells, donor1	11498-119F4	71.47	22.00	3.57	5.64	2.44
Schwann Cells, donor2	11578-120F3	47.63	23.82	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	189.94	58.49	23.66	5.26	1.97
Sebocyte, donor1	11220-116B5	61.35	10.41	6.57	0.55	0.00
Sebocyte, donor2	11301-117B5	91.91	11.95	9.65	0.92	0.46
Sebocyte, donor3	11378-118B1	113.57	21.44	8.45	1.65	0.82
Sertoli Cells, donor1	11255-116F4	177.26	41.41	19.88	4.97	0.00
Sertoli Cells, donor2	11333-117F1	163.81	31.07	11.30	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	21.73	7.65	0.62	1.32	2.02
Skeletal Muscle Cells, donor2	11358-117H8	92.52	26.75	10.12	4.34	2.17
Skeletal Muscle Cells, donor3	11430-118G8	38.46	13.38	5.02	2.51	0.00
Skeletal Muscle Cells, donor4	11451-119A2	152.07	40.84	21.52	4.40	0.94
Skeletal Muscle Cells, donor5	11455-119A6	124.27	35.82	12.34	3.86	0.30
Skeletal Muscle Cells, donor6	11459-119B1	85.11	22.47	7.08	2.62	0.62
Skeletal Muscle Satellite Cells, donor1	11240-116D7	163.68	53.43	16.13	4.16	0.63
Skeletal Muscle Satellite Cells, donor2	11321-117D7	117.00	36.10	9.56	3.85	1.28
Skeletal Muscle Satellite Cells, donor3	11397-118D2	116.08	36.71	16.07	2.78	1.09
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	70.27	21.74	5.39	4.30	1.77
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	21.71	5.79	0.72	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	56.00	19.13	5.50	2.61	1.65
Skin - palm, donor1	10286-104F7	120.87	10.74	10.74	2.69	5.37
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	133.34	16.29	11.82	0.86	0.00
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	67.88	11.45	5.73	0.00	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	139.30	12.59	9.87	0.52	0.13
Small Airway Epithelial Cells, donor1	11256-116F5	113.85	21.27	22.10	1.67	0.14
Small Airway Epithelial Cells, donor2	11334-117F2	96.63	16.74	10.27	1.13	0.00
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	106.99	17.34	15.01	1.06	0.00
Small Airway Epithelial Cells, donor3	11406-118E2	65.81	14.62	7.64	1.50	0.15
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	79.31	13.27	2.47	1.85	0.93
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	166.53	82.04	20.68	12.01	4.89
Smooth Muscle Cells - Aortic, donor0	11210-116A4	35.27	9.99	4.70	0.00	0.59
Smooth Muscle Cells - Aortic, donor1	11283-116I5	50.17	19.45	9.72	2.21	0.66
Smooth Muscle Cells - Aortic, donor2	11360-117I1	78.76	24.41	9.84	1.97	1.18
Smooth Muscle Cells - Aortic, donor3	11432-118H1	35.54	14.68	6.18	1.55	0.77
Smooth Muscle Cells - Bladder, donor1	11519-119H7	138.10	45.03	1.00	12.01	2.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	78.38	14.64	8.52	1.86	0.27
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	89.33	28.82	7.54	4.21	2.66
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	80.53	16.39	7.43	2.82	0.90
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	281.64	81.40	37.44	5.54	2.60
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	396.92	93.62	57.88	6.20	1.48
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	194.75	58.94	32.74	5.13	0.85
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	119.08	45.22	9.92	4.23	0.98
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	110.51	54.19	8.22	5.18	3.65
Smooth Muscle Cells - Carotid, donor1	11285-116I7	48.49	15.15	2.53	1.26	1.01
Smooth Muscle Cells - Carotid, donor2	11362-117I3	12.24	24.48	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	45.78	11.92	6.20	2.86	0.48
Smooth Muscle Cells - Colonic, donor1	11239-116D6	221.36	66.22	25.07	5.16	1.47
Smooth Muscle Cells - Colonic, donor2	11320-117D6	188.76	54.24	23.25	2.15	0.65
Smooth Muscle Cells - Colonic, donor3	11396-118D1	176.33	57.31	22.78	3.88	0.52
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	71.77	21.19	10.36	2.63	0.46
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	65.75	17.25	8.62	3.23	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	78.60	21.82	10.16	2.09	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	61.79	31.75	6.83	2.73	0.68
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	125.73	30.00	5.34	3.22	0.71
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	64.51	27.48	7.25	4.13	1.61
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	109.91	29.58	18.20	2.96	2.28
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	76.68	10.87	5.43	3.02	1.81
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	73.12	26.49	8.48	2.65	0.00
Smooth Muscle Cells - Prostate, donor1	11257-116F6	125.17	37.02	9.59	4.26	1.60
Smooth Muscle Cells - Prostate, donor2	11335-117F3	80.77	37.44	7.89	4.63	1.50
Smooth Muscle Cells - Prostate, donor3	11465-119B7	337.37	129.88	32.98	11.67	1.78
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	83.53	21.41	10.55	2.56	1.51
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	82.52	21.00	6.00	0.75	3.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	62.03	12.92	3.88	2.58	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	53.48	17.21	1.40	2.33	0.93
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	78.76	23.73	9.59	2.02	0.50
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	69.26	18.80	8.46	2.82	2.19
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	137.76	66.96	19.17	3.24	0.88
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	66.81	26.82	4.92	2.25	1.42
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	248.06	92.03	14.48	11.21	2.34
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	61.60	19.57	7.77	2.16	0.14
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	84.90	24.73	8.16	3.06	1.02
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	146.10	22.75	19.93	4.32	1.13
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	145.47	46.53	15.79	3.77	0.98
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	110.60	28.82	7.04	3.44	1.84
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	108.57	38.57	8.10	5.24	0.48
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	63.86	16.88	5.87	1.96	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	211.23	54.80	19.44	5.08	1.99
Smooth Muscle Cells - Uterine, donor3	11466-119B8	301.65	66.12	36.57	3.51	0.29
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	264.33	59.28	24.10	5.25	4.47
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	280.85	75.37	43.90	4.76	0.53
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	565.73	142.83	61.74	9.67	3.35
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	352.51	90.91	40.61	5.03	2.52
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	281.34	65.86	52.24	4.83	1.70
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	219.38	50.81	20.48	1.97	0.79
Smooth muscle cells - airway, control, donor1	11966-126D4	221.95	70.85	14.48	7.62	2.29
Smooth muscle cells - airway, control, donor2	11967-126D5	276.73	93.44	15.57	11.18	7.19
Smooth muscle cells - airway, control, donor3	11968-126D6	358.65	104.92	31.77	6.69	3.34
Smooth muscle cells - airway, control, donor4	11969-126D7	308.02	86.63	36.21	5.04	3.67
Synoviocyte, donor1	11291-117A4	58.41	16.66	3.20	3.53	1.51
Synoviocyte, donor2	11368-117I9	121.02	34.87	11.90	5.36	2.18
Synoviocyte, donor3	11440-118H9	97.18	25.47	6.03	6.93	2.90
Trabecular Meshwork Cells, donor1	11532-120A2	67.89	21.44	6.07	1.79	1.79
Trabecular Meshwork Cells, donor2	11612-122A1	53.52	7.93	7.93	3.96	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	41.68	22.92	4.86	5.33	1.16
Tracheal Epithelial Cells, donor1	11292-117A5	114.98	14.41	8.53	0.93	0.14
Tracheal Epithelial Cells, donor2	11369-118A1	128.73	15.46	14.69	1.55	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	77.31	11.45	9.74	1.15	0.57
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	227.10	49.21	15.62	4.55	1.60
Urethra, donor2	10319-105A4	88.12	46.76	5.40	1.80	0.00
Urothelial Cells, donor1	11520-119H8	109.45	13.02	10.89	0.53	0.27
Urothelial Cells, donor2	11600-120H7	165.83	20.43	16.82	1.60	0.00
Urothelial Cells, donor3	11681-122H7	189.55	19.71	21.77	2.29	0.23
Urothelial cells, donor0	11216-116B1	214.43	24.52	28.98	2.45	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	154.82	48.05	8.01	0.89	0.89
Whole blood (ribopure), donor090309, donation2	12180-129A2	171.55	60.04	2.86	5.72	1.43
Whole blood (ribopure), donor090309, donation3	12181-129A3	125.27	46.55	8.21	2.05	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	132.57	47.52	3.79	2.75	0.69
Whole blood (ribopure), donor090325, donation2	12177-128I8	150.49	53.45	5.81	4.65	1.16
Whole blood (ribopure), donor090612, donation1	12182-129A4	173.89	47.90	6.25	2.08	1.04
Whole blood (ribopure), donor090612, donation2	12183-129A5	164.28	44.05	6.42	1.84	0.92
Whole blood (ribopure), donor090612, donation3	12184-129A6	115.03	39.25	9.13	7.30	1.83
Wilms' tumor cell line:G-401	10809-111A8	133.35	60.08	12.21	2.84	0.12
Wilms' tumor cell line:HFWT	10597-108E3	26.40	13.20	1.76	4.40	2.64
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	188.82	45.81	18.71	3.35	0.00
achilles tendon, donor2	10292-104G4	169.46	35.13	8.27	6.20	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	34.67	31.87	0.25	2.55	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	48.29	23.22	1.86	1.63	0.23
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	26.83	22.91	1.42	3.09	0.59
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	41.36	20.95	1.90	4.08	0.82
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	3.65	4.22	0.00	0.56	0.28
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	247.22	106.80	7.82	14.38	1.06
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	115.15	46.28	4.63	1.36	0.54
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	163.92	49.79	3.53	1.76	0.88
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	345.47	217.25	19.19	7.76	1.63
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	145.61	60.19	3.49	5.44	1.55
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	7.54	10.12	0.18	0.37	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	93.61	54.61	3.90	3.90	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	40.90	21.61	1.39	1.39	0.46
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	48.93	24.85	1.29	2.59	0.26
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	45.30	20.46	2.05	2.05	0.88
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	69.25	41.36	3.25	2.79	0.46
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	278.01	119.26	16.04	5.76	1.23
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	29.16	31.00	1.23	0.61	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	33.71	34.99	2.99	2.99	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	51.56	40.64	3.03	4.25	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	43.33	38.51	2.65	3.37	0.72
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	88.20	52.34	4.45	1.78	1.11
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	13.01	6.00	0.67	1.00	0.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	29.73	26.01	1.86	0.00	1.86
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	32.02	11.68	3.77	0.38	0.38
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	75.01	37.07	3.49	2.62	0.44
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	71.23	18.74	3.75	9.37	0.00
adenocarcinoma cell line:IM95m	10796-110I4	103.86	38.62	3.77	2.12	0.00
adipose tissue, adult, pool1	10010-101C1	255.02	82.21	17.68	8.07	4.19
adipose, donor1	10184-103D4	284.41	60.40	22.87	8.21	0.59
adipose, donor2	10185-103D5	105.43	50.28	7.70	8.92	3.24
adipose, donor3	10186-103D6	103.74	41.39	11.98	8.99	2.45
adipose, donor4	10187-103D7	144.75	35.54	9.53	3.47	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	82.70	105.11	2.84	32.20	4.26
adrenal gland, adult, pool1	10081-102A9	90.94	50.93	10.91	3.64	7.28
adult T-cell leukemia cell line:ATN-1	10421-106C7	60.70	30.68	2.53	2.27	0.27
alveolar cell carcinoma cell line:SW 1573	10708-109H6	276.55	35.37	30.01	2.86	0.00
amniotic membrane cells, donor1	12235-129G3	169.02	44.05	12.75	3.01	0.00
amniotic membrane cells, donor2	12236-129G4	373.60	64.58	23.67	3.38	1.69
amniotic membrane cells, donor3	12237-129G5	294.60	56.27	12.08	4.42	1.18
amygdala - adult, donor10196	10167-103B5	36.76	27.27	0.00	5.93	1.19
amygdala, adult, donor10252	10151-102I7	48.46	30.21	5.27	7.30	4.46
amygdala, newborn, donor10223	10360-105E9	37.76	16.78	1.29	2.26	1.61
anaplastic carcinoma cell line:8305C	10428-106D5	112.56	26.61	3.95	4.07	1.66
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	35.96	18.53	0.66	1.54	0.22
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	39.42	17.37	1.67	3.01	1.00
aorta, adult, pool1	10052-101G7	108.07	44.72	4.71	10.00	3.14
appendix, adult	10189-103D9	153.69	42.69	10.87	6.99	3.10
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	89.42	51.93	7.57	3.78	0.69
artery, adult	10190-103E1	77.45	27.17	6.79	4.08	4.08
astrocytoma cell line:TM-31	10425-106D2	197.16	80.11	17.67	5.79	1.45
b cell line:RPMI1788	10427-106D4	43.12	34.35	1.04	4.16	0.30
basal cell carcinoma cell line:TE 354.T	10702-109G9	84.90	28.30	6.66	6.38	2.77
bile duct carcinoma cell line:HuCCT1	10432-106D9	255.72	29.47	23.02	2.48	0.50
bile duct carcinoma cell line:TFK-1	10496-107C1	27.62	8.20	1.17	0.67	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	30.20	11.18	0.00	0.56	0.00
bladder, adult, pool1	10011-101C2	119.18	37.26	8.04	6.63	2.28
blood, adult, pool1	10053-101G8	152.81	55.37	4.43	4.43	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	115.61	25.69	12.85	0.86	0.86
bone marrow, adult	10192-103E3	332.01	118.09	23.62	14.85	7.42
brain, adult, donor1	10084-102B3	33.83	9.23	1.03	6.15	5.13
brain, adult, pool1	10012-101C3	43.65	35.41	3.12	6.68	6.57
brain, fetal, pool1	10085-102B4	18.70	8.01	2.67	2.67	0.00
breast carcinoma cell line:MCF7	10482-107A5	126.20	32.05	9.58	4.63	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	187.86	25.46	16.60	1.25	0.00
breast, adult, donor1	10080-102A8	158.47	56.82	8.21	10.73	1.26
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	119.54	36.97	11.31	2.67	0.64
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	507.43	113.48	89.67	9.59	0.93
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	126.62	81.27	4.14	14.04	0.23
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	43.33	11.14	5.57	0.48	0.00
carcinoid cell line:NCI-H1770	10703-109H1	88.86	31.50	1.88	4.70	0.00
carcinoid cell line:NCI-H727	10735-110B6	71.21	23.52	7.11	2.41	0.66
carcinoid cell line:SK-PN-DW	10719-109I8	46.90	30.11	2.22	3.49	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	63.88	38.33	3.73	5.59	1.60
caudate nucleus - adult, donor10196	10177-103C6	37.99	29.93	4.61	6.91	5.76
caudate nucleus, adult, donor10252	10164-103B2	41.66	28.95	2.84	7.53	4.35
caudate nucleus, adult, donor10258	10379-105H1	29.04	25.98	4.58	11.46	5.35
caudate nucleus, newborn, donor10223	10354-105E3	33.33	11.72	1.46	2.20	2.93
cerebellum - adult, donor10196	10173-103C2	17.48	20.39	0.00	5.83	0.00
cerebellum, adult, donor10252	10166-103B4	17.72	11.32	0.21	1.07	3.20
cerebellum, adult, pool1	10083-102B2	19.66	14.14	1.38	5.86	2.07
cerebellum, newborn, donor10223	10357-105E6	17.44	7.47	0.83	0.83	4.98
cerebral meninges, adult	10188-103D8	67.32	31.27	7.31	9.58	4.54
cerebrospinal fluid, donor2	10294-104G6	95.75	21.20	3.65	4.39	1.46
cervical cancer cell line:D98-AH2	10552-107I3	37.67	6.61	2.88	0.72	0.14
cervical cancer cell line:ME-180	10553-107I4	122.80	18.23	11.60	0.83	0.00
cervix, adult, pool1	10013-101C4	165.67	61.52	10.71	9.34	5.35
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	221.13	54.48	25.22	4.46	1.81
chondrosarcoma cell line:SW 1353	10700-109G7	118.87	32.66	16.98	6.53	0.00
choriocarcinoma cell line:BeWo	10423-106C9	213.38	41.26	22.49	2.36	0.62
choriocarcinoma cell line:SCH	10785-110H2	251.85	39.92	22.55	2.83	0.25
choriocarcinoma cell line:T3M-3	10618-108G6	221.29	50.76	15.42	3.79	0.24
chorionic membrane cells, donor1	12238-129G6	247.31	77.78	24.50	4.56	1.14
chorionic membrane cells, donor2	12239-129G7	460.07	58.17	53.89	6.96	1.09
chorionic membrane cells, donor3	12240-129G8	315.40	63.19	15.39	7.14	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	42.41	17.17	5.05	1.01	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	62.82	33.81	3.46	2.69	0.58
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	100.52	42.87	9.71	2.32	0.21
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	11.81	7.19	0.51	0.51	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	15.96	6.53	0.24	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	10.59	6.92	0.20	0.20	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	24.44	14.43	1.18	1.77	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	136.83	35.45	11.99	2.87	0.78
clear cell carcinoma cell line:JHOC-5	10638-108I8	139.89	80.46	19.20	7.31	1.83
clear cell carcinoma cell line:TEN	10636-108I6	191.38	46.85	12.32	2.43	0.69
colon carcinoma cell line:CACO-2	10513-107D9	245.64	75.96	16.66	4.03	0.55
colon carcinoma cell line:COLO-320	10420-106C6	52.83	23.95	3.04	2.28	0.00
colon, adult, donor1	10082-102B1	90.44	19.04	2.38	5.95	0.00
colon, adult, pool1	10014-101C5	152.40	36.78	11.52	4.00	2.23
colon, fetal, donor1	10070-101I7	132.25	34.61	5.56	7.42	1.24
common myeloid progenitor CMP, donor1	12130-128D6	22.92	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	300.44	75.11	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	20.82	14.02	1.27	0.42	0.42
cord blood derived cell line:COBL-a 24h infection	10453-106G3	29.88	23.39	3.47	2.72	0.15
cord blood derived cell line:COBL-a untreated	10449-106F8	34.41	25.24	2.96	3.24	0.71
corpus callosum, adult, pool1	10042-101F6	96.74	66.23	8.84	16.58	9.51
cruciate ligament, donor2	10295-104G7	132.92	23.50	12.16	4.86	0.81
diaphragm, fetal, donor1	10069-101I6	65.01	16.05	4.01	4.82	4.82
diencephalon, adult	10193-103E4	52.32	48.00	3.84	7.68	8.40
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	22.04	15.84	0.92	0.92	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	127.71	23.59	11.54	1.80	0.51
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	204.13	58.01	27.20	4.09	0.72
ductus deferens, adult	10196-103E7	857.64	111.13	151.99	18.94	3.99
duodenum, fetal, donor1, tech_rep1	10071-101I8	132.50	70.57	10.08	7.20	1.44
duodenum, fetal, donor1, tech_rep2	10071-101I8	187.59	47.82	13.98	4.41	2.94
dura mater, adult, donor1	10041-101F5	415.91	116.37	45.75	10.82	3.55
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	27.98	13.55	5.55	0.67	0.22
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	86.41	22.07	7.88	1.29	0.00
embryonic pancreas cell line:1B2C6	10604-108F1	162.79	24.05	17.27	5.55	1.23
embryonic pancreas cell line:1C3D3	10605-108F2	60.54	20.28	4.54	1.51	0.91
embryonic pancreas cell line:1C3IKEI	10606-108F3	83.05	16.67	7.10	1.23	0.93
embryonic pancreas cell line:2C6	10603-108E9	174.69	14.45	14.45	2.63	1.31
endometrial carcinoma cell line:OMC-2	10497-107C2	94.19	33.85	9.39	1.01	1.01
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	195.01	61.98	18.12	16.67	5.80
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	167.25	53.07	18.01	2.89	0.32
epidermoid carcinoma cell line:A431	10426-106D3	162.96	18.45	18.12	1.00	0.00
epidermoid carcinoma cell line:Ca Ski	10431-106D8	361.74	53.67	57.19	3.08	0.55
epididymis, adult	10197-103E8	6264.47	414.65	1125.47	110.10	12.14
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	67.24	44.00	6.03	3.37	0.35
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	66.06	15.73	5.11	0.79	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	83.74	17.04	7.99	1.05	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	85.53	18.60	6.59	2.56	0.10
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	80.66	18.93	5.60	1.23	0.00
esophagus, adult, pool1	10015-101C6	129.22	33.34	9.56	3.82	2.02
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	342.40	84.03	28.43	10.27	0.88
eye - muscle inferior rectus, donor1	10272-104E2	19.32	14.49	4.83	0.00	7.24
eye - muscle lateral, donor2	10298-104H1	69.44	23.15	6.31	2.10	8.42
eye - muscle medial, donor2	10299-104H2	22.32	19.35	0.00	1.49	4.46
eye - muscle superior, donor2	10297-104G9	59.62	28.66	2.29	4.59	3.44
eye - vitreous humor, donor1	10268-104D7	83.07	24.78	7.29	0.00	0.00
eye, fetal, donor1	10054-101G9	112.12	53.39	7.88	9.66	4.83
fibrosarcoma cell line:HT-1080	10758-110E2	110.53	26.93	13.98	3.21	0.13
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	44.16	12.35	1.66	1.66	0.47
frontal lobe, adult, pool1	10040-101F4	22.33	18.01	1.03	4.50	3.47
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	71.46	26.72	8.71	1.20	0.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	87.78	32.37	5.21	4.85	1.19
gall bladder, adult	10198-103E9	118.78	41.53	8.21	10.38	1.93
gamma delta positive T cells, donor1	11937-126A2	53.15	22.55	1.61	2.15	0.54
gamma delta positive T cells, donor2	11938-126A3	73.20	28.39	1.87	4.48	1.49
gastric adenocarcinoma cell line:MKN1	10614-108G2	63.15	12.67	13.31	0.42	0.21
gastric adenocarcinoma cell line:MKN45	10612-108F9	42.94	19.15	1.93	1.35	0.19
gastric cancer cell line:AZ521	10549-107H9	96.24	81.16	7.21	17.87	0.98
gastric cancer cell line:GSS	10560-108A2	43.93	30.20	0.92	10.07	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	64.88	23.99	4.11	4.57	1.14
giant cell carcinoma cell line:LU65	10487-107B1	51.17	5.85	4.13	0.23	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	132.54	41.43	9.38	3.50	1.12
glassy cell carcinoma cell line:HOKUG	10688-109F4	86.30	14.22	6.98	0.75	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	50.88	13.93	7.71	2.01	0.74
glioblastoma cell line:A172, tech_rep2	10444-106F3	49.01	13.90	7.02	1.12	0.42
glioblastoma cell line:T98G	10485-107A8	52.54	16.00	7.40	2.10	0.33
glioma cell line:GI-1	10413-106B8	108.36	40.12	4.69	2.64	0.29
globus pallidus - adult, donor10196	10175-103C4	45.19	47.38	0.73	10.93	8.02
globus pallidus, adult, donor10252	10161-103A8	129.13	72.98	10.01	10.74	8.54
globus pallidus, adult, donor10258	10367-105F7	78.04	67.09	2.74	6.85	15.06
globus pallidus, newborn, donor10223	10364-105F4	42.63	21.32	3.20	4.80	3.20
granulocyte macrophage progenitor, donor1	12131-128D7	24.47	7.34	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	131.14	153.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	297.92	135.89	20.91	5.23	5.23
granulosa cell tumor cell line:KGN	10624-108H3	319.04	54.40	30.72	5.76	1.60
hIPS +CCl2, biol_rep1	14383-156B9	212.11	67.49	21.58	3.67	1.38
hIPS +CCl2, biol_rep2	14384-156C1	193.88	53.50	24.23	0.46	0.00
hIPS +CCl2, biol_rep3	14385-156C2	225.43	73.43	14.17	1.29	1.93
hIPS, biol_rep1	14380-156B6	143.73	43.12	5.75	0.00	0.00
hIPS, biol_rep2	14381-156B7	193.41	53.50	12.35	0.69	0.69
hIPS, biol_rep3	14382-156B8	64.00	32.00	3.31	2.21	5.52
hairy cell leukemia cell line:Mo	10712-109I1	28.16	22.41	2.01	2.87	0.57
heart - mitral valve, adult	10205-103F7	88.79	55.01	6.28	12.56	3.59
heart - pulmonic valve, adult	10206-103F8	67.46	27.72	4.71	6.54	2.35
heart - tricuspid valve, adult	10207-103F9	43.30	15.82	2.50	3.33	1.67
heart, adult, diseased post-infarction, donor1	10050-101G5	90.81	59.58	7.96	5.92	2.04
heart, adult, diseased, donor1	10051-101G6	62.17	32.79	7.66	6.81	2.55
heart, adult, pool1	10016-101C7	71.75	25.99	6.21	3.45	2.53
heart, fetal, pool1	10046-101G1	134.61	49.49	13.35	9.96	2.88
hepatic mesenchymal tumor cell line:LI90	10778-110G4	86.08	33.63	7.71	4.94	4.01
hepatoblastoma cell line:HuH-6	10633-108I3	151.03	14.27	7.14	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	120.11	42.65	12.49	2.10	0.55
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	120.40	44.67	15.05	2.43	0.36
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	115.50	44.36	13.24	2.53	0.61
hepatoma cell line:Li-7	10484-107A7	55.39	14.35	5.12	0.00	0.00
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	32.16	19.10	1.31	0.90	0.40
hippocampus - adult, donor10196	10169-103B7	32.18	29.34	1.89	3.79	1.89
hippocampus, adult, donor10252	10153-102I9	64.70	43.47	3.06	5.92	5.51
hippocampus, adult, donor10258	10374-105G5	22.91	15.93	1.99	0.50	1.49
hippocampus, newborn, donor10223	10363-105F3	18.33	7.05	0.70	1.41	1.06
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	297.24	60.42	28.08	4.88	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	153.75	35.74	16.89	3.34	0.59
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	194.99	44.69	24.37	4.57	0.25
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	204.68	72.74	9.59	8.46	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	232.39	96.83	15.23	11.36	1.29
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	264.97	88.45	26.95	8.35	0.76
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	183.64	62.77	20.14	9.34	0.58
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	186.56	84.66	15.73	13.36	2.80
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	173.92	67.15	22.52	8.34	3.75
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	193.46	64.64	25.81	8.05	2.84
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	180.81	68.30	23.30	9.80	1.61
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	217.48	77.43	21.55	10.10	0.67
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	149.29	34.43	16.12	4.54	0.78
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	169.01	36.85	14.74	1.97	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	316.81	59.35	27.06	6.11	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	168.00	49.64	13.55	6.11	0.19
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	144.34	47.53	9.16	4.80	1.31
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	186.41	52.97	16.49	5.00	0.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	163.52	76.49	16.20	11.68	2.26
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	173.70	93.22	13.19	14.10	3.18
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	185.44	72.36	19.73	5.95	3.45
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	111.70	42.13	15.19	8.65	2.12
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	132.09	51.09	12.48	6.39	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	105.52	40.95	12.85	6.88	4.18
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	190.29	49.33	21.06	4.99	0.55
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	154.62	47.07	19.11	2.57	0.86
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	276.84	68.60	29.40	6.12	0.82
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	221.46	73.94	17.25	8.80	1.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	188.46	63.35	14.89	5.07	1.58
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	229.08	70.51	29.66	7.26	1.82
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	162.38	62.05	9.31	7.76	2.07
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	179.99	59.77	16.60	5.98	2.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	148.02	43.10	16.42	2.31	1.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	178.70	64.93	21.73	9.20	2.81
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	170.38	62.85	17.42	7.57	2.27
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	202.31	66.88	25.54	8.07	1.68
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	194.90	53.61	20.53	2.42	0.24
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	242.88	57.49	32.98	5.35	0.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	211.22	55.12	16.59	5.37	0.98
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	210.88	78.85	17.42	9.47	2.14
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	1011.76	289.54	130.13	39.04	3.25
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	325.65	91.01	27.14	8.94	1.32
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	177.87	84.83	14.23	9.85	1.64
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	216.04	78.17	17.37	9.41	2.90
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	197.51	83.99	19.57	8.54	0.71
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	128.89	44.16	20.29	5.97	1.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	165.22	61.89	17.33	10.43	2.30
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	158.94	54.15	19.13	7.81	3.77
immature langerhans cells, donor1	11904-125F5	56.90	15.50	2.91	0.97	0.97
immature langerhans cells, donor2	11905-125F6	57.83	19.01	3.17	3.17	0.79
insula, adult, pool1	10039-101F3	21.86	20.35	1.89	4.16	3.22
keratoacanthoma cell line:HKA-1	10791-110H8	204.52	36.74	22.11	2.28	0.65
kidney, adult, pool1	10017-101C8	234.50	70.19	31.74	4.91	1.30
kidney, fetal, pool1	10045-101F9	147.55	58.22	13.65	8.98	2.26
large cell lung carcinoma cell line:IA-LM	10509-107D5	79.25	10.79	3.55	0.99	0.28
large cell lung carcinoma cell line:NCI-H460	10839-111E2	27.51	16.73	0.83	2.63	0.83
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	296.72	29.73	22.20	2.57	0.55
left atrium, adult, donor1	10079-102A7	247.36	93.71	21.79	13.62	3.27
left ventricle, adult, donor1	10078-102A6	89.00	45.00	9.10	5.06	5.06
leiomyoblastoma cell line:G-402	10721-110A1	169.64	30.92	18.61	2.46	0.00
leiomyoma cell line:10964C	10569-108B2	506.54	128.97	108.85	8.98	5.03
leiomyoma cell line:15242A	10570-108B3	428.81	70.11	94.02	10.87	1.09
leiomyoma cell line:15425	10571-108B4	255.68	65.80	47.83	7.28	1.46
leiomyosarcoma cell line:Hs 5.T	10722-110A2	107.94	31.75	25.40	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	279.16	41.82	55.41	0.00	1.05
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	25.97	9.80	2.60	0.12	0.47
liposarcoma cell line:KMLS-1	10782-110G8	64.05	33.27	6.40	5.47	2.97
liposarcoma cell line:SW 872	10726-110A6	213.46	44.96	22.05	2.68	1.22
liver, adult, pool1	10018-101C9	87.03	21.55	7.94	2.27	0.65
liver, fetal, pool1	10086-102B5	58.32	28.22	3.76	4.70	0.00
locus coeruleus - adult, donor10196	10182-103D2	49.73	37.19	3.06	10.94	6.27
locus coeruleus, adult, donor10252	10165-103B3	83.23	50.94	5.35	8.12	2.95
locus coeruleus, adult, donor10258	10375-105G6	74.20	52.20	5.92	16.36	11.85
locus coeruleus, newborn, donor10223	10362-105F2	82.86	38.28	7.57	3.79	3.36
lung adenocarcinoma cell line:A549	10499-107C4	94.39	37.50	6.50	3.18	0.14
lung adenocarcinoma cell line:PC-14	10408-106B3	459.14	82.73	74.46	8.27	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	204.71	55.36	32.95	5.40	0.26
lung, adult, pool1	10019-101D1	580.83	74.42	51.98	8.27	2.24
lung, fetal, donor1	10068-101I5	861.07	78.20	52.51	15.13	7.99
lung, right lower lobe, adult, donor1	10075-102A3	713.44	121.43	54.53	16.50	3.21
lymph node, adult, donor1	10077-102A5	309.11	91.83	27.93	10.41	1.42
lymphangiectasia cell line:DS-1	10727-110A7	43.18	39.01	1.97	3.73	0.22
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	10.72	9.96	0.45	0.91	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	67.96	5.10	10.19	0.00	0.00
mature adipocyte, donor1	12231-129F8	65.71	27.97	1.33	4.44	3.11
mature adipocyte, donor2	12232-129F9	65.37	31.34	3.74	4.36	2.49
mature adipocyte, donor3	12233-129G1	68.27	36.03	4.74	5.93	1.90
mature adipocyte, donor4	12234-129G2	71.86	30.53	3.42	6.05	0.79
maxillary sinus tumor cell line:HSQ-89	10414-106B9	61.71	26.21	3.34	2.38	0.48
medial frontal gyrus - adult, donor10196	10170-103B8	11.28	21.43	0.00	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	49.84	29.79	3.68	3.68	4.60
medial frontal gyrus, adult, donor10258	10368-105F8	17.16	14.93	1.59	2.22	2.54
medial frontal gyrus, newborn, donor10223	10352-105E1	25.59	8.53	2.56	3.41	1.28
medial temporal gyrus - adult, donor10196	10183-103D3	25.14	18.23	1.35	3.71	2.87
medial temporal gyrus, adult, donor10252	10156-103A3	49.02	28.86	3.18	4.24	2.97
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	5.78	19.26	0.00	1.93	3.85
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	0.00	28.71	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	16.51	4.67	1.44	1.08	0.00
medulla oblongata - adult, donor10196	10174-103C3	257.64	133.04	31.80	9.09	6.49
medulla oblongata, adult, donor10252	10155-103A2	158.52	79.10	18.89	11.46	3.72
medulla oblongata, adult, pool1	10038-101F2	86.44	58.12	10.77	13.55	8.16
medulla oblongata, newborn, donor10223	10361-105F1	62.49	27.43	4.51	9.72	6.25
medulloblastoma cell line:D283 Med	10838-111E1	94.99	23.03	4.21	1.11	0.22
medulloblastoma cell line:ONS-76	10759-110E3	144.89	24.70	13.08	2.32	0.37
melanoma cell line:COLO 679	10514-107E1	158.12	62.10	23.72	2.30	0.43
melanoma cell line:G-361	10465-106H6	58.64	31.49	3.80	1.09	0.81
meningioma cell line:HKBMM	10691-109F7	140.56	28.22	14.11	2.35	0.00
merkel cell carcinoma cell line:MKL-1	10843-111E6	14.98	7.93	0.88	3.52	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	9.85	7.00	0.78	0.52	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	108.17	31.30	11.20	3.84	0.31
mesenchymal precursor cell - adipose, donor2	11748-123G2	99.43	30.36	15.09	2.73	0.73
mesenchymal precursor cell - adipose, donor3	11749-123G3	157.77	34.78	19.88	5.38	2.07
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	201.44	61.25	25.29	7.59	1.40
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	348.74	92.24	57.96	11.36	1.93
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	145.76	80.51	19.43	5.55	2.08
mesenchymal precursor cell - cardiac, donor1	11752-123G6	334.17	87.53	60.93	8.07	1.54
mesenchymal precursor cell - cardiac, donor2	11753-123G7	271.44	80.40	43.59	8.63	1.73
mesenchymal precursor cell - cardiac, donor3	11754-123G8	133.70	32.89	16.18	3.18	0.66
mesenchymal precursor cell - cardiac, donor4	11755-123G9	204.45	46.72	28.49	4.86	0.95
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	154.78	32.86	20.77	3.13	1.00
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	200.91	46.77	25.69	5.27	0.33
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	133.81	39.44	17.43	3.32	0.55
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	207.36	69.47	32.46	5.93	2.79
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	230.09	69.82	36.55	6.12	1.22
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	224.30	54.64	31.27	4.31	1.44
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	217.24	76.04	23.59	9.52	3.00
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	295.71	61.10	57.45	1.82	1.14
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	281.10	62.09	50.35	3.78	0.42
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	186.65	48.42	27.80	4.78	0.45
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	189.94	46.65	28.10	4.29	0.79
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	445.47	114.50	54.86	9.57	0.74
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	275.00	45.21	37.49	6.58	1.14
mesenchymal stem cell line:Hu5/E18	10568-108B1	38.73	17.26	3.79	0.42	0.84
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	68.04	33.79	4.11	4.57	1.83
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	83.13	27.11	7.42	2.81	1.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	71.72	30.10	6.54	4.19	1.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	66.55	26.50	5.24	2.46	2.77
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	72.96	23.54	6.12	3.53	1.88
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	79.54	28.09	5.42	2.03	1.69
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	68.77	27.51	6.68	1.96	2.36
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	70.43	27.80	4.17	2.78	2.32
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	48.30	48.30	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	78.16	31.73	7.79	4.04	0.58
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	70.95	29.45	5.35	2.23	1.12
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	78.84	26.92	6.01	2.88	1.68
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	71.87	19.80	4.40	2.93	1.47
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	71.83	28.87	8.06	4.70	1.68
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	72.87	32.34	6.14	2.05	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	71.31	27.49	4.30	2.58	2.58
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	60.16	32.81	8.20	5.47	2.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	98.13	30.99	15.49	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	81.52	26.96	5.85	3.57	0.97
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	80.02	32.01	8.73	1.45	2.91
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	77.30	26.65	5.86	2.67	1.07
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	53.16	22.08	6.54	1.64	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	73.47	22.93	3.89	3.11	1.55
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	79.75	23.09	4.20	4.20	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	83.45	28.81	1.99	1.99	1.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	85.81	33.37	4.77	0.00	9.53
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	90.72	26.68	7.71	1.19	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	76.76	24.37	7.31	2.44	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	27.05	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	78.54	29.14	5.70	5.07	0.63
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	70.71	24.49	4.83	1.38	3.10
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	83.82	36.54	2.15	4.30	4.30
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	59.88	19.96	3.99	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	65.43	37.88	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	79.86	26.49	3.26	4.07	2.44
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	85.80	27.81	3.18	1.59	4.77
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	86.66	24.17	1.18	4.13	2.95
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	67.95	26.18	3.74	4.68	4.36
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	85.55	34.75	5.35	4.01	5.35
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	74.51	31.93	9.46	5.91	3.55
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	87.31	20.54	2.57	2.57	5.14
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	79.17	31.67	3.44	8.95	3.44
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	276.60	40.57	41.07	4.95	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	187.29	33.65	15.70	8.97	4.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	242.98	39.44	29.26	4.45	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	573.04	58.03	78.58	3.63	0.40
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	710.87	50.15	102.49	17.44	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	584.11	55.75	58.28	2.53	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	408.44	52.19	32.77	5.46	0.61
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	429.30	40.67	45.19	4.52	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	373.95	47.77	34.59	4.12	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	182.55	42.26	17.86	6.15	4.17
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	186.26	37.64	16.55	6.49	2.92
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	167.05	34.63	13.24	8.15	6.11
mesodermal tumor cell line:HIRS-BM	10696-109G3	75.05	16.25	3.09	10.06	2.32
mesothelioma cell line:ACC-MESO-1	10493-107B7	66.38	44.65	7.09	6.61	0.47
mesothelioma cell line:ACC-MESO-4	10494-107B8	183.95	55.14	22.94	4.17	0.46
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	81.20	25.64	12.82	4.27	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	181.97	27.54	17.26	1.85	0.31
mesothelioma cell line:Mero-25	10850-111F4	58.33	7.26	10.89	0.45	0.45
mesothelioma cell line:Mero-41	10851-111F5	216.85	43.52	33.98	2.93	1.22
mesothelioma cell line:Mero-48a	10852-111F6	123.34	21.26	13.95	1.99	0.22
mesothelioma cell line:Mero-82	10853-111F7	143.23	19.71	19.71	2.10	0.00
mesothelioma cell line:Mero-83	10854-111F8	129.03	21.45	10.38	1.19	0.34
mesothelioma cell line:Mero-84	10855-111F9	273.25	42.21	29.57	4.04	0.76
mesothelioma cell line:Mero-95	10856-111G1	284.48	43.69	35.82	3.52	0.62
mesothelioma cell line:NCI-H2052	10847-111F1	91.27	16.07	15.24	0.83	0.66
mesothelioma cell line:NCI-H226	10846-111E9	316.01	30.23	48.14	3.08	0.00
mesothelioma cell line:NCI-H2452	10848-111F2	117.01	19.64	11.79	1.88	0.00
mesothelioma cell line:NCI-H28	10845-111E8	45.55	13.74	6.36	0.76	0.00
mesothelioma cell line:No36	10857-111G2	167.34	38.82	20.22	1.63	0.00
mesothelioma cell line:ONE58	10858-111G3	131.68	34.41	24.11	1.63	0.27
migratory langerhans cells, donor1	11901-125F2	48.75	27.64	1.92	3.26	1.15
migratory langerhans cells, donor2	11902-125F3	25.89	16.12	0.98	1.34	0.49
migratory langerhans cells, donor3	11903-125F4	68.92	42.90	2.15	5.38	3.05
mixed mullerian tumor cell line:HTMMT	10689-109F5	105.13	39.83	15.34	1.96	0.98
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	194.98	84.14	46.84	6.99	1.70
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	106.19	10.37	8.52	0.46	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	17.70	18.65	1.14	2.28	0.57
myelodysplastic syndrome cell line:SKM-1	10772-110F7	41.76	15.34	1.29	1.11	0.18
myeloma cell line:PCM6	10474-106I6	294.13	155.37	22.14	11.27	1.58
myxofibrosarcoma cell line:MFH-ino	10600-108E6	221.18	21.31	19.28	3.04	0.51
myxofibrosarcoma cell line:NMFH-1	10684-109E9	233.41	57.47	27.46	2.75	0.39
nasal epithelial cells, donor1, tech_rep1	12226-129F3	135.16	30.53	8.36	2.01	0.11
nasal epithelial cells, donor1, tech_rep2	12226-129F3	169.36	28.83	13.02	2.13	0.29
nasal epithelial cells, donor2	12227-129F4	155.11	28.70	19.87	3.31	0.55
neuroblastoma cell line:CHP-134	10508-107D4	0.46	0.46	0.00	0.23	0.00
neuroblastoma cell line:NB-1	10539-107G8	10.10	4.86	0.56	1.68	0.19
neuroblastoma cell line:NBsusSR	10607-108F4	57.99	23.62	6.54	2.95	1.05
neuroblastoma cell line:NH-12	10555-107I6	3.54	0.56	0.00	0.19	0.19
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	20.88	9.96	0.47	2.61	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	51.47	15.36	2.22	2.69	0.32
neuroectodermal tumor cell line:TASK1	10774-110F9	119.15	28.38	2.21	7.04	0.40
neuroepithelioma cell line:SK-N-MC	10728-110A8	33.06	22.25	0.64	3.81	3.18
neurofibroma cell line:Hs 53.T	10729-110A9	56.96	9.32	3.46	1.60	0.27
neutrophil PMN, donor1	12133-128D9	14.87	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	66.40	13.28	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	132.59	75.77	0.00	9.47	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	29.93	26.72	1.52	3.55	0.00
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	32.02	16.81	1.60	1.60	2.40
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	65.72	41.68	4.49	5.77	3.85
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	93.02	29.43	10.25	3.68	1.05
nucleus accumbens, adult, pool1	10037-101F1	26.43	20.72	1.22	6.56	3.84
occipital cortex - adult, donor10196	10172-103C1	22.66	10.30	2.06	2.06	2.06
occipital cortex, adult, donor10252	10163-103B1	76.75	37.57	5.10	5.90	5.10
occipital cortex, newborn, donor10223	10355-105E4	25.84	8.01	0.36	1.82	1.09
occipital lobe, adult, donor1	10076-102A4	23.35	19.16	1.05	4.46	2.89
occipital lobe, fetal, donor1	10073-102A1	6.01	2.15	0.00	0.86	0.43
occipital pole, adult, pool1	10036-101E9	19.71	16.24	1.10	4.81	3.23
olfactory region, adult	10195-103E6	34.20	27.70	1.53	6.69	6.30
optic nerve, donor1	10277-104E7	26.01	32.02	0.00	22.01	12.01
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	101.38	11.50	15.61	0.34	0.00
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	199.21	51.25	12.09	2.20	0.00
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	395.20	51.31	55.20	3.22	0.51
oral squamous cell carcinoma cell line:SAS	10544-107H4	465.27	38.23	45.51	3.81	0.35
osteoclastoma cell line:Hs 706.T	10704-109H2	192.55	27.04	26.16	4.70	0.88
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	97.17	18.69	6.54	3.74	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	186.40	71.04	20.78	7.63	1.91
ovary, adult, pool1	10020-101D2	135.74	54.51	7.95	10.66	7.95
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	76.63	22.92	4.22	2.20	0.73
pancreas, adult, donor1	10049-101G4	98.77	42.33	2.82	5.64	0.94
pancreatic carcinoma cell line:NOR-P1	10698-109G5	299.10	43.61	23.76	2.52	0.28
papillary adenocarcinoma cell line:8505C	10437-106E5	54.51	10.39	6.64	0.34	0.34
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	781.22	66.40	68.72	17.22	1.82
paracentral gyrus, adult, pool1	10035-101E8	21.87	16.84	1.28	5.58	3.48
parietal cortex, adult, donor10258	10373-105G4	22.02	20.55	0.73	0.73	1.47
parietal lobe - adult, donor10196	10171-103B9	25.39	22.57	0.94	2.82	0.94
parietal lobe, adult, donor10252	10157-103A4	39.34	28.79	2.57	3.71	3.42
parietal lobe, adult, pool1	10034-101E7	24.67	19.74	1.59	6.87	3.17
parietal lobe, fetal, donor1	10072-101I9	9.70	9.70	0.00	7.76	0.00
parietal lobe, newborn, donor10223	10356-105E5	24.30	4.49	3.36	1.12	1.12
parotid gland, adult	10199-103F1	94.35	45.02	5.55	7.40	0.62
penis, adult	10200-103F2	113.33	37.06	6.45	4.30	2.69
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	109.14	19.34	5.39	2.79	0.37
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	255.11	81.73	29.58	2.19	0.29
pineal gland - adult, donor10196	10179-103C8	28.38	23.22	1.29	2.58	3.87
pineal gland, adult, donor10252	10160-103A7	51.52	34.35	4.74	4.15	1.18
pineal gland, adult, donor10258	10377-105G8	34.49	25.08	0.63	7.52	2.51
pituitary gland - adult, donor10196	10180-103C9	73.86	116.36	5.06	13.15	2.02
pituitary gland, adult, donor10252	10162-103A9	124.04	132.38	11.99	16.68	8.34
pituitary gland, adult, donor10258	10378-105G9	96.19	86.83	5.11	23.83	5.11
placenta, adult, pool1	10021-101D3	164.05	49.56	12.79	4.73	2.69
plasma cell leukemia cell line:ARH-77	10840-111E3	33.11	35.76	1.72	3.84	0.26
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	663.49	53.23	63.35	5.14	1.56
pons, adult, pool1	10033-101E6	40.02	26.94	2.50	8.09	4.99
postcentral gyrus, adult, pool1	10032-101E5	18.92	17.87	1.39	4.88	2.62
promyelocytes/myelocytes PMC, donor1	12132-128D8	6.27	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	446.15	236.85	16.52	16.52	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	328.60	258.19	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	133.86	53.02	16.17	6.12	0.44
prostate cancer cell line:PC-3	10439-106E7	135.76	31.58	10.71	3.27	0.00
prostate, adult, pool1	10022-101D4	140.03	48.79	8.71	7.89	3.45
putamen, adult, donor10196	10176-103C5	20.07	17.94	1.65	4.01	3.54
putamen, adult, donor10252	10152-102I8	131.37	33.33	5.88	0.00	1.96
putamen, adult, donor10258, tech_rep1	10372-105G3	81.96	25.13	4.37	4.37	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	27.06	20.05	1.21	4.35	3.62
putamen, newborn, donor10223	10365-105F5	66.72	19.49	6.00	7.50	3.00
rectal cancer cell line:TT1TKB	10469-106I1	130.92	20.07	7.27	0.87	0.00
rectum, fetal, donor1	10067-101I4	66.77	25.04	1.39	9.74	6.95
renal cell carcinoma cell line:OS-RC-2	10411-106B6	88.19	25.02	9.12	2.54	0.21
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	30.65	22.78	0.41	3.73	0.83
retina, adult, pool1	10030-101E3	383.48	124.95	59.14	13.82	3.68
retinoblastoma cell line:Y79	10475-106I7	21.30	9.87	1.30	1.56	0.26
rhabdomyosarcoma cell line:KYM-1	10787-110H4	59.38	29.14	3.32	3.07	0.25
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	54.55	19.68	1.12	1.97	0.56
sacrococcigeal teratoma cell line:HTST	10695-109G2	72.75	15.91	3.79	3.03	0.76
salivary acinar cells, donor1	11771-123I7	222.55	36.90	17.32	2.27	0.16
salivary acinar cells, donor2	11772-123I8	334.44	38.41	28.36	2.75	0.14
salivary acinar cells, donor3	11773-123I9	232.38	25.16	19.86	1.99	1.32
salivary gland, adult, pool1	10093-102C3	130.41	37.75	7.44	1.72	3.43
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	135.40	58.85	14.42	4.38	0.93
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	133.66	65.24	13.28	5.52	0.35
seminal vesicle, adult	10201-103F3	480.93	82.01	89.94	8.99	2.65
serous adenocarcinoma cell line:JHOS-2	10639-108I9	293.70	58.79	36.92	3.16	0.49
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	200.30	76.24	20.38	3.52	1.01
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	79.28	29.10	10.04	1.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	195.71	45.67	11.01	2.28	0.54
signet ring carcinoma cell line:Kato III	10436-106E4	54.60	17.79	6.30	0.33	0.00
signet ring carcinoma cell line:NUGC-4	10483-107A6	74.06	23.35	5.68	1.03	0.13
skeletal muscle - soleus muscle, donor1	10282-104F3	19.86	8.51	0.71	2.13	0.71
skeletal muscle, adult, pool1	10023-101D5	76.40	18.23	4.80	2.40	0.72
skeletal muscle, fetal, donor1	10066-101I3	69.35	24.12	1.01	4.02	3.02
skin, adult, donor1	10074-102A2	196.77	74.64	6.79	6.79	0.00
skin, fetal, donor1	10065-101I2	97.84	32.82	3.79	5.05	5.05
small cell cervical cancer cell line:HCSC-1	10800-110I8	40.02	28.68	4.67	2.00	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	118.20	35.62	5.99	6.30	0.95
small cell lung carcinoma cell line:DMS 144	10841-111E4	52.23	80.95	0.96	29.10	1.93
small cell lung carcinoma cell line:LK-2	10541-107H1	23.90	11.37	0.99	0.33	0.00
small cell lung carcinoma cell line:NCI-H82	10842-111E5	40.05	26.70	0.48	1.61	0.16
small cell lung carcinoma cell line:WA-hT	10562-108A4	51.86	37.92	4.79	1.96	1.31
small intestine, adult, pool1	10024-101D6	199.95	46.10	22.69	2.63	1.31
small intestine, fetal, donor1	10064-101I1	320.63	71.99	31.94	5.90	3.44
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	34.88	26.67	3.08	1.54	1.03
smooth muscle, adult, pool1	10048-101G3	74.69	31.53	3.88	4.39	3.36
somatostatinoma cell line:QGP-1	10781-110G7	17.69	12.06	0.27	0.54	0.00
spinal cord - adult, donor10196	10181-103D1	105.07	67.67	8.49	22.71	8.26
spinal cord, adult, donor10252	10159-103A6	164.81	85.95	8.28	11.83	12.22
spinal cord, adult, donor10258	10369-105F9	188.17	112.07	11.07	10.38	8.99
spinal cord, fetal, donor1	10056-101H2	54.28	35.98	4.27	9.15	5.49
spinal cord, newborn, donor10223	10359-105E8	124.91	40.41	8.73	11.02	4.13
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	34.35	8.81	1.79	0.75	0.30
spleen, adult, pool1	10025-101D7	222.47	78.31	19.93	7.93	1.87
spleen, fetal, pool1	10044-101F8	148.42	54.19	10.65	6.75	2.46
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	32.71	16.25	1.24	2.17	0.21
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	89.05	23.73	4.56	1.14	0.19
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	131.39	82.12	11.88	9.44	0.70
squamous cell carcinoma cell line:T3M-5	10616-108G4	155.59	10.16	5.08	0.39	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	149.59	23.64	27.91	1.13	0.00
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	69.47	20.33	2.97	0.85	0.42
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	133.27	36.38	21.58	1.69	0.00
stomach, fetal, donor1	10062-101H8	176.22	71.55	9.61	9.61	5.34
submaxillary gland, adult	10202-103F4	128.18	47.28	11.96	5.13	2.28
substantia nigra - adult, donor10196	10178-103C7	54.27	108.55	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	121.09	68.34	7.48	11.63	6.23
substantia nigra, adult, donor10258	10371-105G2	38.79	40.86	5.17	6.21	3.62
substantia nigra, newborn, donor10223	10358-105E7	82.67	26.14	9.89	7.07	5.65
synovial sarcoma cell line:HS-SY-II	10441-106E9	82.31	42.18	6.42	6.65	0.23
temporal lobe, adult, pool1	10031-101E4	28.57	25.52	2.03	6.27	4.49
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	7.83	6.41	0.71	2.85	2.85
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	22.86	5.71	1.76	2.20	1.32
tenocyte, donor1	11763-123H8	89.02	31.42	8.03	3.84	2.44
tenocyte, donor2	11765-123I1	224.71	73.25	20.60	9.16	6.87
tenocyte, donor3	11768-123I4	87.11	29.28	9.27	3.71	2.97
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	74.27	33.99	5.95	4.25	0.68
teratocarcinoma cell line:NCR-G1	10798-110I6	1604.84	231.53	141.97	42.70	6.94
teratocarcinoma cell line:PA-1	10807-111A6	156.53	39.52	8.52	5.27	0.15
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	153.86	35.16	14.47	3.43	0.25
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	147.87	30.25	8.70	2.27	1.13
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	243.43	26.72	10.58	3.60	0.00
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	225.06	63.51	20.19	8.14	0.98
testis, adult, pool1	10026-101D8	372.37	71.40	41.45	11.27	4.19
testis, adult, pool2	10096-102C6	190.36	60.90	26.61	5.86	4.51
thalamus - adult, donor10196	10168-103B6	48.58	37.54	5.52	14.35	6.62
thalamus, adult, donor10252	10154-103A1	91.74	46.26	6.88	7.81	6.10
thalamus, adult, donor10258, tech_rep1	10370-105G1	58.51	27.71	3.08	4.62	13.86
thalamus, adult, donor10258, tech_rep2	10370-105G1	52.54	44.30	3.79	10.38	6.75
thalamus, newborn, donor10223	10366-105F6	45.45	13.23	1.15	4.60	1.73
throat, adult	10209-103G2	123.59	39.45	11.48	4.24	2.50
throat, fetal, donor1	10061-101H7	113.66	59.42	7.92	11.27	3.05
thymic carcinoma cell line:Ty-82	10803-111A2	56.84	22.66	1.19	2.19	0.20
thymus, adult, pool1	10027-101D9	57.76	23.36	3.98	4.37	0.99
thymus, fetal, pool1	10043-101F7	93.31	35.22	7.48	4.36	1.25
thyroid carcinoma cell line:KHM-5M	10776-110G2	115.41	29.52	10.90	2.53	0.40
thyroid carcinoma cell line:TCO-1	10783-110G9	412.65	44.98	32.97	4.89	0.56
thyroid, adult, pool1	10028-101E1	444.36	148.83	38.44	16.14	4.01
thyroid, fetal, donor1	10060-101H6	145.54	89.91	6.86	11.34	3.95
tongue epidermis (fungiform papillae), donor1	10288-104F9	110.87	43.11	6.16	6.16	0.00
tongue, adult	10203-103F5	106.52	37.44	8.37	4.65	2.09
tongue, fetal, donor1	10059-101H5	85.12	41.38	2.36	7.09	1.58
tonsil, adult, pool1	10047-101G2	141.75	53.39	12.62	4.71	1.60
trachea, adult, pool1	10029-101E2	140.37	44.91	11.62	4.09	1.55
trachea, fetal, donor1	10058-101H4	84.63	42.70	6.92	5.77	5.77
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	101.68	19.49	10.27	3.54	0.35
transitional-cell carcinoma cell line:5637	10418-106C4	272.64	40.02	34.45	2.53	0.81
transitional-cell carcinoma cell line:JMSU1	10492-107B6	83.20	21.31	2.04	2.35	0.00
tridermal teratoma cell line:HGRT	10694-109G1	64.69	17.12	1.90	5.71	3.81
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	63.49	15.91	2.12	1.02	0.25
umbilical cord, fetal, donor1	10057-101H3	89.72	35.47	12.52	6.26	6.26
uterus, adult, pool1	10100-102D1	123.19	43.17	5.63	6.14	4.95
uterus, fetal, donor1	10055-101H1	110.06	48.12	6.66	10.75	3.58
vagina, adult	10204-103F6	111.79	37.48	5.17	10.34	0.65
vein, adult	10191-103E2	169.44	55.90	15.56	7.45	3.51
xeroderma pigentosum b cell line:XPL 17	10563-108A5	39.52	16.56	0.80	1.87	0.27